Allianz/2025/FY/Financial supplement: Difference between revisions
Appearance
Content deleted Content added
PlumBot: publish from draft |
PlumBot: publish from draft |
||
| Line 17: | Line 17: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Spot foreign exchange rates by currency for June 2024, December 2024, June 2025, and December 2025 {{footnote|1=Source: WM/Reuters.}} |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="4" style="text-align:center" | Spot |
! colspan="4" style="text-align:center" | Spot |
||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! class="col- |
! class="col-s" style="text-align:right" | 30.06.2024 |
||
! class="col-s" style="text-align:right" | 31.12.2024 |
! class="col-s" style="text-align:right" | 31.12.2024 |
||
! class="col-s" style="text-align:right" | 30.06.2025 |
! class="col-s" style="text-align:right" | 30.06.2025 |
||
| Line 28: | Line 28: | ||
|- |
|- |
||
| style="text-align:left" | '''USD''' |
| style="text-align:left" | '''USD''' |
||
| style="text-align:right" | |
| style="text-align:right" | 1.0717 |
||
| style="text-align:right" | '''1.0355''' |
| style="text-align:right" | '''1.0355''' |
||
| style="text-align:right" | 1.1739 |
| style="text-align:right" | 1.1739 |
||
| Line 55: | Line 55: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Average foreign exchange rates by currency for |
|+ Average foreign exchange rates by currency for 2024 and 2025 |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | Average |
! colspan="2" style="text-align:center" | Average |
||
| Line 82: | Line 82: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable fintable" |
||
|+ Discount rates |
|+ Discount rates by contract type, currency, and maturity for December 2024 and March 2025 {{footnote|1=The table sets out the continuously compounded market rates used to discount the cash flows of insurance contracts for major currencies. Source: LSEG Data & Analytics; internal processing of market quotes.}} |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="5" style="text-align:center" | 31.12.2024 |
! colspan="5" style="text-align:center" | 31.12.2024 |
||
| Line 89: | Line 89: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | 1 year |
! class="col-s" style="text-align:right" | 1 year |
||
! style="text-align:right" | 5 years |
! class="col-s" style="text-align:right" | 5 years |
||
! style="text-align:right" | 10 years |
! class="col-s" style="text-align:right" | 10 years |
||
! style="text-align:right" | 20 years |
! class="col-s" style="text-align:right" | 20 years |
||
! style="text-align:right" | 30 years |
! class="col-s" style="text-align:right" | 30 years |
||
! style="text-align:right" | 1 year |
! class="col-s" style="text-align:right" | 1 year |
||
|- |
|- |
||
| style="text-align:left" | '''Unit-linked contracts''' |
| style="text-align:left" | '''Unit-linked contracts''' |
||
| Line 105: | Line 105: | ||
|- |
|- |
||
| style="text-align:left" | EUR |
| style="text-align:left" | EUR |
||
| style="text-align:right" | |
| style="text-align:right" | 2.27 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.18 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.30 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.29 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.38 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.18 |
||
|- |
|- |
||
| style="text-align:left" | USD |
| style="text-align:left" | USD |
||
| style="text-align:right" | |
| style="text-align:right" | 4.09 |
||
| style="text-align:right" | |
| style="text-align:right" | 3.94 |
||
| style="text-align:right" | |
| style="text-align:right" | 3.99 |
||
| style="text-align:right" | |
| style="text-align:right" | 4.02 |
||
| style="text-align:right" | 3.80 |
| style="text-align:right" | 3.80 |
||
| style="text-align:right" | 3.90 |
| style="text-align:right" | 3.90 |
||
| Line 129: | Line 129: | ||
|- |
|- |
||
| style="text-align:left" | EUR |
| style="text-align:left" | EUR |
||
| style="text-align:right" | |
| style="text-align:right" | 2.55 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.46 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.58 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.58 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.62 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.45 |
||
|- |
|- |
||
| style="text-align:left" | USD |
| style="text-align:left" | USD |
||
| style="text-align:right" | |
| style="text-align:right" | 4.64 |
||
| style="text-align:right" | |
| style="text-align:right" | 4.49 |
||
| style="text-align:right" | |
| style="text-align:right" | 4.53 |
||
| style="text-align:right" | |
| style="text-align:right" | 4.57 |
||
| style="text-align:right" | |
| style="text-align:right" | 4.33 |
||
| style="text-align:right" | |
| style="text-align:right" | 4.59 |
||
|- |
|||
| style="text-align:left" | '''Traditional participating and other insurance contracts {{footnote|1=Ranges in valuation rates reflect different liquidity characteristics of insurance portfolios in a given currency.}}''' |
|||
| ⚫ | |||
| ⚫ | |||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | EUR |
|||
| style="text-align:right" | 2.47 - 3.11 |
|||
| style="text-align:right" | 2.38 - 3.02 |
|||
| style="text-align:right" | 2.50 - 3.14 |
|||
| style="text-align:right" | 2.49 - 3.13 |
|||
| style="text-align:right" | 2.55 - 3.08 |
|||
| style="text-align:right" | 2.36 - 3.00 |
|||
|- |
|||
| style="text-align:left" | USD |
|||
| style="text-align:right" | 5.34 - 5.41 |
|||
| style="text-align:right" | 5.19 - 5.25 |
|||
| style="text-align:right" | 5.24 - 5.30 |
|||
| style="text-align:right" | 5.27 - 5.34 |
|||
| style="text-align:right" | 5.00 - 5.06 |
|||
| style="text-align:right" | 5.19 - 5.37 |
|||
|} |
|} |
||
</div> |
</div> |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable fintable" |
||
|+ Discount rates |
|+ Discount rates by contract type, currency, and maturity for June 2025 and September 2025 |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="5" style="text-align:center" | 30.06.2025 |
! colspan="5" style="text-align:center" | 30.06.2025 |
||
| Line 154: | Line 178: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! style="text-align:right" | 1 year |
! class="col-s" style="text-align:right" | 1 year |
||
! style="text-align:right" | 5 years |
! class="col-s" style="text-align:right" | 5 years |
||
! style="text-align:right" | 10 years |
! class="col-s" style="text-align:right" | 10 years |
||
! style="text-align:right" | 20 years |
! class="col-s" style="text-align:right" | 20 years |
||
! style="text-align:right" | 30 years |
! class="col-s" style="text-align:right" | 30 years |
||
! style="text-align:right" | 1 year |
! class="col-s" style="text-align:right" | 1 year |
||
|- |
|- |
||
| style="text-align:left" | '''Unit-linked contracts''' |
| style="text-align:left" | '''Unit-linked contracts''' |
||
| Line 171: | Line 195: | ||
| style="text-align:left" | EUR |
| style="text-align:left" | EUR |
||
| style="text-align:right" | 1.93 |
| style="text-align:right" | 1.93 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.20 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.54 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.76 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.82 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.05 |
||
|- |
|- |
||
| style="text-align:left" | USD |
| style="text-align:left" | USD |
||
| Line 194: | Line 218: | ||
|- |
|- |
||
| style="text-align:left" | EUR |
| style="text-align:left" | EUR |
||
| style="text-align:right" | |
| style="text-align:right" | 2.19 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.45 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.79 |
||
| style="text-align:right" | 3.01 |
| style="text-align:right" | 3.01 |
||
| style="text-align:right" | 3.04 |
| style="text-align:right" | 3.04 |
||
| style="text-align:right" | |
| style="text-align:right" | 2.26 |
||
|- |
|- |
||
| style="text-align:left" | USD |
| style="text-align:left" | USD |
||
| style="text-align:right" | |
| style="text-align:right" | 4.51 |
||
| style="text-align:right" | |
| style="text-align:right" | 4.09 |
||
| style="text-align:right" | |
| style="text-align:right" | 4.36 |
||
| style="text-align:right" | 4.67 |
| style="text-align:right" | 4.67 |
||
| style="text-align:right" | 4.54 |
| style="text-align:right" | 4.54 |
||
| style="text-align:right" | 4.17 |
| style="text-align:right" | 4.17 |
||
|- |
|||
| style="text-align:left" | '''Traditional participating and other insurance contracts³''' |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | EUR |
|||
| style="text-align:right" | 1.93 - 2.68 |
|||
| style="text-align:right" | 2.20 - 2.94 |
|||
| style="text-align:right" | 2.54 - 3.28 |
|||
| style="text-align:right" | 2.76 - 3.51 |
|||
| style="text-align:right" | 2.82 - 3.47 |
|||
| style="text-align:right" | 2.05 - 2.75 |
|||
|- |
|||
| style="text-align:left" | USD |
|||
| style="text-align:right" | 5.09 - 5.29 |
|||
| style="text-align:right" | 4.67 - 4.87 |
|||
| style="text-align:right" | 4.95 - 5.15 |
|||
| style="text-align:right" | 5.25 - 5.45 |
|||
| style="text-align:right" | 5.10 - 5.29 |
|||
| style="text-align:right" | 4.69 - 4.95 |
|||
|} |
|} |
||
</div> |
</div> |
||
| Line 213: | Line 261: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Discount rates |
|+ Discount rates by contract type, currency, and maturity for December 2025 |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="5" style="text-align:center" | 31.12.2025 |
! colspan="5" style="text-align:center" | 31.12.2025 |
||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! class="col- |
! class="col-s" style="text-align:right" | 1 year |
||
! class="col-s" style="text-align:right" | 5 years |
! class="col-s" style="text-align:right" | 5 years |
||
! class="col-s" style="text-align:right" | 10 years |
! class="col-s" style="text-align:right" | 10 years |
||
| Line 232: | Line 280: | ||
|- |
|- |
||
| style="text-align:left" | EUR |
| style="text-align:left" | EUR |
||
| style="text-align:right" | |
| style="text-align:right" | 2.09 |
||
| style="text-align:right" | 2.49 |
| style="text-align:right" | 2.49 |
||
| style="text-align:right" | 2.86 |
| style="text-align:right" | 2.86 |
||
| Line 265: | Line 313: | ||
| style="text-align:right" | 4.75 |
| style="text-align:right" | 4.75 |
||
| style="text-align:right" | 4.67 |
| style="text-align:right" | 4.67 |
||
|- |
|||
| style="text-align:left" | '''Traditional participating and other insurance contracts³''' |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | EUR |
|||
| style="text-align:right" | 2.09 - 2.74 |
|||
| style="text-align:right" | 2.49 - 3.14 |
|||
| style="text-align:right" | 2.86 - 3.51 |
|||
| style="text-align:right" | 3.20 - 3.84 |
|||
| style="text-align:right" | 3.25 - 3.80 |
|||
|- |
|||
| style="text-align:left" | USD |
|||
| style="text-align:right" | 4.40 - 4.63 |
|||
| style="text-align:right" | 4.44 - 4.67 |
|||
| style="text-align:right" | 4.79 - 5.02 |
|||
| style="text-align:right" | 5.22 - 5.44 |
|||
| style="text-align:right" | 5.11 - 5.33 |
|||
|} |
|} |
||
</div> |
</div> |
||
| Line 272: | Line 341: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Total assets |
|+ Total assets build-up by asset type for June 2024, December 2024, June 2025, and December 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! style="text-align:center" | |
! style="text-align:center" | |
||
| Line 343: | Line 412: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Total assets |
|+ Total assets build-up by asset type for June 2024, December 2024, June 2025, and December 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! style="text-align:center" | |
! style="text-align:center" | |
||
| Line 414: | Line 483: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Total assets |
|+ Total assets build-up by asset type for June 2024, December 2024, June 2025, and December 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! style="text-align:center" | |
! style="text-align:center" | |
||
| Line 485: | Line 554: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Total assets build-up for June 30, 2024, December 31, 2024, June 30, 2025, and December 31, 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! style="text-align:center" | |
! style="text-align:center" | |
||
| Line 556: | Line 625: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Total assets build-up for June 30, 2024, December 31, 2024, June 30, 2025, and December 31, 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! style="text-align:center" | |
! style="text-align:center" | |
||
| Line 627: | Line 696: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Total assets build-up for June 30, 2024, December 31, 2024, June 30, 2025, and December 31, 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! style="text-align:center" | |
! style="text-align:center" | |
||
| Line 698: | Line 767: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Total liabilities and equity build-up for June 30, 2024, December 31, 2024, June 30, 2025, and December 31, 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | 30.06.2024 |
! class="col-s" style="text-align:right" | 30.06.2024 |
||
| Line 811: | Line 880: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Total liabilities and equity build-up for June 30, 2024, December 31, 2024, June 30, 2025, and December 31, 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | 30.06.2024 |
! class="col-s" style="text-align:right" | 30.06.2024 |
||
| Line 888: | Line 957: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Total liabilities and equity build-up for June 30, 2024, December 31, 2024, June 30, 2025, and December 31, 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | 30.06.2024 |
! class="col-s" style="text-align:right" | 30.06.2024 |
||
| Line 965: | Line 1,034: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Total liabilities and equity build-up for June 30, 2024, December 31, 2024, June 30, 2025, and December 31, 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | 30.06.2024 |
! class="col-s" style="text-align:right" | 30.06.2024 |
||
| Line 1,042: | Line 1,111: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Total liabilities and equity build-up for June 30, 2024, December 31, 2024, June 30, 2025, and December 31, 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | 30.06.2024 |
! class="col-s" style="text-align:right" | 30.06.2024 |
||
| Line 1,119: | Line 1,188: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Total liabilities and equity build-up for fiscal years 2024 and 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-m" style="text-align:right" | 30.06.2024 |
! class="col-m" style="text-align:right" | 30.06.2024 |
||
| Line 1,194: | Line 1,263: | ||
</div> |
</div> |
||
== |
== Shareholders’ Equity == |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Shareholders' equity rollforward for |
|+ Shareholders' equity rollforward for 12M 25 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! style="text-align:center" | Allianz |
! style="text-align:center" | Allianz group |
||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
| Line 1,242: | Line 1,311: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Shareholders' equity sensitivity |
|+ Shareholders' equity sensitivity to market movements as of 31.12.2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="2" style="text-align:center" | As of 31.12.2025 |
! colspan="2" style="text-align:center" | As of 31.12.2025 |
||
| Line 1,284: | Line 1,353: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Solvency II own funds and SCR rollforward for 4Q |
|+ Solvency II own funds and SCR rollforward for 4Q 25 and 12M 25 |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:center" | 4Q 25 |
! style="text-align:center" | 4Q 25 |
||
| Line 1,306: | Line 1,375: | ||
| style="text-align:right" | '''7%-p''' |
| style="text-align:right" | '''7%-p''' |
||
|- |
|- |
||
| style="text-align:left" | Operating SII earnings / business |
| style="text-align:left" | Operating SII earnings / business evolution� {{footnote|1=Operating SII earnings after tax/before dividend.}} |
||
| style="text-align:right" | 3.1 |
| style="text-align:right" | 3.1 |
||
| style="text-align:right" | 13.0 |
| style="text-align:right" | 13.0 |
||
| Line 1,312: | Line 1,381: | ||
| style="text-align:right" | '''25%-p''' |
| style="text-align:right" | '''25%-p''' |
||
|- |
|- |
||
| style="text-align:left" | Property- |
| style="text-align:left" | Property-casualty |
||
| style="text-align:right" | 1.6 |
| style="text-align:right" | 1.6 |
||
| style="text-align:right" | 6.8 |
| style="text-align:right" | 6.8 |
||
| Line 1,318: | Line 1,387: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Life/ |
| style="text-align:left" | Life/health |
||
| style="text-align:right" | 1.1 |
| style="text-align:right" | 1.1 |
||
| style="text-align:right" | 4.9 |
| style="text-align:right" | 4.9 |
||
| Line 1,324: | Line 1,393: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Asset |
| style="text-align:left" | Asset management |
||
| style="text-align:right" | 0.7 |
| style="text-align:right" | 0.7 |
||
| style="text-align:right" | 2.3 |
| style="text-align:right" | 2.3 |
||
| Line 1,336: | Line 1,405: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Market |
| style="text-align:left" | Market impact� {{footnote|1=For SCR including cross effects and policyholder participation.}} |
||
| style="text-align:right" | 1.1 |
| style="text-align:right" | 1.1 |
||
| style="text-align:right" | -0.2 |
| style="text-align:right" | -0.2 |
||
| Line 1,348: | Line 1,417: | ||
| style="text-align:right" | '''-20%-p''' |
| style="text-align:right" | '''-20%-p''' |
||
|- |
|- |
||
| style="text-align:left" | Management actions, debt and |
| style="text-align:left" | Management actions, debt and other� {{footnote|1=Other effects on SCR include diversification effects.}} |
||
| style="text-align:right" | -1.2 |
| style="text-align:right" | -1.2 |
||
| style="text-align:right" | -2.0 |
| style="text-align:right" | -2.0 |
||
| Line 1,376: | Line 1,445: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable" |
||
|+ Solvency II ratio sensitivity |
|+ Solvency II ratio sensitivity to market movements as of 31.12.2025 {{footnote|1=After tax.}} |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! colspan="2" style="text-align:center" | As of 31.12.2025 |
! colspan="2" style="text-align:center" | As of 31.12.2025 |
||
| Line 1,420: | Line 1,489: | ||
| style="text-align:right" | '''219%''' |
| style="text-align:right" | '''219%''' |
||
|- |
|- |
||
| style="text-align:left" | Combined |
| style="text-align:left" | Combined scenario�⁵ (IR -50bps, CS +50bps, EQ -30%) {{footnote|1=Including cross effects.}} |
||
| style="text-align:right" | -22%-p |
| style="text-align:right" | -22%-p |
||
| style="text-align:right" | '''196%''' |
| style="text-align:right" | '''196%''' |
||
| Line 1,430: | Line 1,499: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Financial assets breakdown by segment and asset type for fiscal years 2024 and 2025 |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! colspan="2" style="text-align:center" | Property-Casualty |
! colspan="2" style="text-align:center" | Property-Casualty |
||
| Line 1,449: | Line 1,518: | ||
! class="col-s" style="text-align:right" | 31.12.2025 |
! class="col-s" style="text-align:right" | 31.12.2025 |
||
! class="col-s" style="text-align:right" | 31.12.2024 |
! class="col-s" style="text-align:right" | 31.12.2024 |
||
! class="col- |
! class="col-s" style="text-align:right" | 31.12.2025 |
||
! class="col-s" style="text-align:right" | 31.12.2024 |
! class="col-s" style="text-align:right" | 31.12.2024 |
||
! class="col-s" style="text-align:right" | 31.12.2025 |
! class="col-s" style="text-align:right" | 31.12.2025 |
||
|- |
|- |
||
| style="text-align:left" | Net cash |
| style="text-align:left" | Net cash investments� {{footnote|1=Net of liabilities from securities lending and including liabilities from cash pooling.}} |
||
| style="text-align:right" | 11.4 |
| style="text-align:right" | 11.4 |
||
| style="text-align:right" | '''9.2''' |
| style="text-align:right" | '''9.2''' |
||
| Line 1,607: | Line 1,676: | ||
| style="text-align:right" | '''11.2''' |
| style="text-align:right" | '''11.2''' |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Derivatives� {{footnote|1=Net of liabilities.}} |
||
| style="text-align:right" | -0.2 |
| style="text-align:right" | -0.2 |
||
| style="text-align:right" | '''0.2''' |
| style="text-align:right" | '''0.2''' |
||
| Line 1,635: | Line 1,704: | ||
| style="text-align:right" | '''27.6''' |
| style="text-align:right" | '''27.6''' |
||
|- |
|- |
||
| style="text-align:left" | Real |
| style="text-align:left" | Real estate� {{footnote|1=Excludes real estate held for own use measured at amortized cost.}} |
||
| style="text-align:right" | 3.9 |
| style="text-align:right" | 3.9 |
||
| style="text-align:right" | '''3.2''' |
| style="text-align:right" | '''3.2''' |
||
| Line 1,687: | Line 1,756: | ||
| style="text-align:right" | '''42.3''' |
| style="text-align:right" | '''42.3''' |
||
| style="text-align:right" | '''-6.9''' |
| style="text-align:right" | '''-6.9''' |
||
| style="text-align:right" | '''- |
| style="text-align:right" | '''-5.9''' |
||
| style="text-align:right" | '''767.0''' |
| style="text-align:right" | '''767.0''' |
||
| style="text-align:right" | '''764.2''' |
| style="text-align:right" | '''764.2''' |
||
| Line 1,725: | Line 1,794: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Gross and net contractual service margin (CSM) rollforward by segment for 12M 25 |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | 12M |
! colspan="3" style="text-align:center" | 12M |
||
| Line 1,732: | Line 1,801: | ||
! class="col-s" style="text-align:right" | Life/Health |
! class="col-s" style="text-align:right" | Life/Health |
||
! class="col-s" style="text-align:right" | Property-Casualty |
! class="col-s" style="text-align:right" | Property-Casualty |
||
! class="col-s" style="text-align:right" | Allianz |
! class="col-s" style="text-align:right" | Allianz group� {{footnote|1=Life/Health and Property-Casualty figures don't add up due to consolidation effects.}} |
||
|- |
|- |
||
| ⚫ | | style="text-align:left" | '''Opening gross CSM� {{footnote|1=Life/Health and Group include gross CSM of EUR 0.8bn as of 31.12.2024 and 01.01.2025 for UniCredit Allianz Vita S.p.A., which was classified as held for sale in the 3Q 24. Effective 01.01.2025, the German APR and the Austrian health businesses have been transferred from the Property-Casualty segment to the Life/Health segment resulting in a EUR 1.2bn shift in the gross CSM opening balance.}}''' |
||
| ⚫ | |||
| style="text-align:right" | '''56,789''' |
| style="text-align:right" | '''56,789''' |
||
| style="text-align:right" | '''64''' |
| style="text-align:right" | '''64''' |
||
| Line 1,773: | Line 1,842: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Gross contractual service margin (CSM) rollforward for life/health for 12M 25 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! style="text-align:center" | Life/Health |
! style="text-align:center" | Life/Health |
||
| Line 1,780: | Line 1,849: | ||
! class="col-s" style="text-align:right" | 12M |
! class="col-s" style="text-align:right" | 12M |
||
|- |
|- |
||
| ⚫ | |||
| ⚫ | | style="text-align:left" | '''Opening gross |
||
| style="text-align:right" | '''56,789''' |
| style="text-align:right" | '''56,789''' |
||
|- |
|- |
||
| Line 1,798: | Line 1,867: | ||
| style="text-align:right" | '''-5,440''' |
| style="text-align:right" | '''-5,440''' |
||
|- |
|- |
||
| style="text-align:left" | Change in |
| style="text-align:left" | Change in scope� {{footnote|1=The change in scope refers to the sale of UniCredit Allianz Vita S.p.A., which was completed in 2Q 25.}} |
||
| style="text-align:right" | '''-802''' |
| style="text-align:right" | '''-802''' |
||
|- |
|- |
||
| Line 1,808: | Line 1,877: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Contractual service margin (CSM) sensitivity |
|+ Contractual service margin (CSM) sensitivity by equity markets, interest rate, and credit spread for fiscal year 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="2" style="text-align:center" | Life/health |
! colspan="2" style="text-align:center" | Life/health |
||
| Line 1,850: | Line 1,919: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Operating profit build-up |
|+ Operating profit build-up for fiscal years 2024 and 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
|- |
|- |
||
| style="text-align:left" | '''Total business volume {{footnote|1= |
| style="text-align:left" | '''Total business volume {{footnote|1=Total business volume comprises gross premiums written and fee and commission income in Property-Casualty, statutory gross premiums in Life/Health, and operating revenues in Asset Management.}}''' |
||
| style="text-align:right" | '''179,778''' |
| style="text-align:right" | '''179,778''' |
||
| style="text-align:right" | '''186,938''' |
| style="text-align:right" | '''186,938''' |
||
| Line 2,019: | Line 2,088: | ||
| style="text-align:right" | '''11,113''' |
| style="text-align:right" | '''11,113''' |
||
|- |
|- |
||
| style="text-align:left" | '''Core return on equity {{footnote|1= |
| style="text-align:left" | '''Core return on equity³ (in %) {{footnote|1=For current year periods and prior year periods, the core return on equity for the respective full year is shown.}}''' |
||
| style="text-align:right" | '''16.9''' |
| style="text-align:right" | '''16.9''' |
||
| style="text-align:right" | '''18.1''' |
| style="text-align:right" | '''18.1''' |
||
|- |
|- |
||
| style="text-align:left" | '''Average shareholders' |
| style="text-align:left" | '''Average shareholders' equity⁴ used for core RoE calculation {{footnote|1=Shareholders‘ equity excluding undated subordinated bonds classified as shareholders’ equity, unrealized gains and losses from insurance contracts and other unrealized gains and losses.}}''' |
||
| style="text-align:right" | '''58,544''' |
| style="text-align:right" | '''58,544''' |
||
| style="text-align:right" | '''60,619''' |
| style="text-align:right" | '''60,619''' |
||
| Line 2,033: | Line 2,102: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Earnings per share (EPS) time series |
|+ Earnings per share (EPS) time series for fiscal years 2024 and 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-m" style="text-align:right" | 2024 |
! class="col-m" style="text-align:right" | 2024 |
||
| Line 2,058: | Line 2,127: | ||
| style="text-align:right" | '''382,958,691''' |
| style="text-align:right" | '''382,958,691''' |
||
|- |
|- |
||
| style="text-align:left" | Net income attributable to shareholders - basic {{footnote|1= |
| style="text-align:left" | Net income attributable to shareholders - basic {{footnote|1=Adjusted for net financial charges related to undated subordinated bonds classified as shareholders’ equity. For core EPS basic and core EPS diluted, net financial charges excluding any foreign currency translation effects incurred in the redemption of these bonds.}} |
||
| style="text-align:right" | '''9,788''' |
| style="text-align:right" | '''9,788''' |
||
| style="text-align:right" | '''10,603''' |
| style="text-align:right" | '''10,603''' |
||
| Line 2,078: | Line 2,147: | ||
| style="text-align:right" | '''27.67''' |
| style="text-align:right" | '''27.67''' |
||
|- |
|- |
||
| style="text-align:left" | Shareholders' core net income - basic |
| style="text-align:left" | Shareholders' core net income - basic |
||
| style="text-align:right" | '''9,874''' |
| style="text-align:right" | '''9,874''' |
||
| style="text-align:right" | '''10,953''' |
| style="text-align:right" | '''10,953''' |
||
| Line 2,104: | Line 2,173: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Property-casualty operating profit build-up for fiscal years 2024 and 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
|- |
|- |
||
| style="text-align:left" | '''Total business volume {{footnote|1= |
| style="text-align:left" | '''Total business volume {{footnote|1=Total business volume comprises gross premiums written and fee and commission income.}}''' |
||
| style="text-align:right" | '''82,883''' |
| style="text-align:right" | '''82,883''' |
||
| style="text-align:right" | '''86,741''' |
| style="text-align:right" | '''86,741''' |
||
| Line 2,153: | Line 2,222: | ||
| style="text-align:right" | '''-1,336''' |
| style="text-align:right" | '''-1,336''' |
||
|- |
|- |
||
| style="text-align:left" | Valuation result & other {{footnote|1= |
| style="text-align:left" | Valuation result & other {{footnote|1=Other comprises realized gains/losses, investment expenses, F/X gains/losses on insurance assets/liabilities and other.}} |
||
| style="text-align:right" | '''-811''' |
| style="text-align:right" | '''-811''' |
||
| style="text-align:right" | '''-549''' |
| style="text-align:right" | '''-549''' |
||
| Line 2,269: | Line 2,338: | ||
| style="text-align:right" | '''5,991''' |
| style="text-align:right" | '''5,991''' |
||
|- |
|- |
||
| style="text-align:left" | '''Loss |
| style="text-align:left" | '''Loss ratio⁵ (in %) {{footnote|1=Reinsurance ratio: 3.8% in 4Q 25 (4Q 24: 1.9%), 3.8% in 12M 25 (12M 24: 3.9%).}}''' |
||
| style="text-align:right" | '''69.3''' |
| style="text-align:right" | '''69.3''' |
||
| style="text-align:right" | '''68.3''' |
| style="text-align:right" | '''68.3''' |
||
| Line 2,297: | Line 2,366: | ||
| style="text-align:right" | '''92.2''' |
| style="text-align:right" | '''92.2''' |
||
|- |
|- |
||
| style="text-align:left" | '''Core return on |
| style="text-align:left" | '''Core return on equity⁶ (in %) {{footnote|1=For current year periods and prior year periods, the core return on equity for the respective full year is shown.}}''' |
||
| style="text-align:right" | '''13.5''' |
| style="text-align:right" | '''13.5''' |
||
| style="text-align:right" | '''15.1''' |
| style="text-align:right" | '''15.1''' |
||
| Line 2,311: | Line 2,380: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Property-casualty |
|+ Property-casualty breakdown by region for 12 months 2024 and 12 months 2025 |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | EUR mn |
! colspan="2" style="text-align:center" | EUR mn |
||
| Line 2,320: | Line 2,389: | ||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! style="text-align:center" | Total business volume {{footnote|1=Total business volume comprises gross premiums written and fee and commission income.}} |
! style="text-align:center" | Total business volume {{footnote|1=Total business volume comprises gross premiums written and fee and commission income.}} |
||
! style="text-align:center" | Total business volume |
! colspan="2" style="text-align:center" | Total business volume |
||
| ⚫ | |||
! colspan="2" style="text-align:center" | Operating insurance revenue |
! colspan="2" style="text-align:center" | Operating insurance revenue |
||
! colspan="2" style="text-align:center" | Operating profit (loss) |
! colspan="2" style="text-align:center" | Operating profit (loss) |
||
| Line 2,334: | Line 2,402: | ||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
! class="col- |
! class="col-s" style="text-align:right" | Internal growth {{footnote|1=This reflects the growth of total business volume on an internal basis, adjusted for foreign currency translation and (de-)consolidation effects.}} |
||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
| Line 2,469: | Line 2,537: | ||
| style="text-align:right" | 299 |
| style="text-align:right" | 299 |
||
| style="text-align:right" | '''283''' |
| style="text-align:right" | '''283''' |
||
| style="text-align:right" | '''- |
| style="text-align:right" | '''-5.4''' |
||
| style="text-align:right" | 272 |
| style="text-align:right" | 272 |
||
| style="text-align:right" | '''286''' |
| style="text-align:right" | '''286''' |
||
| Line 2,586: | Line 2,654: | ||
| style="text-align:right" | '''19.1''' |
| style="text-align:right" | '''19.1''' |
||
|- |
|- |
||
| style="text-align:left; padding-left:1.5em" | Thereof: AGCS excluding fronting & captives {{footnote|1= |
| style="text-align:left; padding-left:1.5em" | Thereof: AGCS excluding fronting & captives {{footnote|1=Internal growth exlcudes Arch transaction.}} |
||
| style="text-align:right" | 7,880 |
| style="text-align:right" | 7,880 |
||
| style="text-align:right" | '''7,788''' |
| style="text-align:right" | '''7,788''' |
||
| Line 2,787: | Line 2,855: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Property-casualty |
|+ Property-casualty breakdown by region for 4Q 2024 and 4Q 2025 |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | EUR mn |
! colspan="2" style="text-align:center" | EUR mn |
||
| Line 2,795: | Line 2,863: | ||
|- |
|- |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! style="text-align:center" | Total business volume {{footnote|1= |
! style="text-align:center" | Total business volume {{footnote|1=Total business volume comprises gross premiums written and fee and commission income.}} |
||
! style="text-align:center" | Total business volume |
! colspan="2" style="text-align:center" | Total business volume |
||
| ⚫ | |||
! colspan="2" style="text-align:center" | Operating insurance revenue |
! colspan="2" style="text-align:center" | Operating insurance revenue |
||
! colspan="2" style="text-align:center" | Operating profit (loss) |
! colspan="2" style="text-align:center" | Operating profit (loss) |
||
| Line 2,821: | Line 2,888: | ||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
! class="col- |
! class="col-s" style="text-align:right" | Internal growth {{footnote|1=This reflects the growth of total business volume on an internal basis, adjusted for foreign currency translation and (de-)consolidation effects.}} |
||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
| Line 2,866: | Line 2,933: | ||
| style="text-align:right" | 1,083 |
| style="text-align:right" | 1,083 |
||
| style="text-align:right" | '''1,108''' |
| style="text-align:right" | '''1,108''' |
||
| style="text-align:right" | ''' |
| style="text-align:right" | '''5.2''' |
||
| style="text-align:right" | 1,123 |
| style="text-align:right" | 1,123 |
||
| style="text-align:right" | '''1,148''' |
| style="text-align:right" | '''1,148''' |
||
| Line 2,911: | Line 2,978: | ||
| style="text-align:right" | 1,147 |
| style="text-align:right" | 1,147 |
||
| style="text-align:right" | '''1,214''' |
| style="text-align:right" | '''1,214''' |
||
| style="text-align:right" | ''' |
| style="text-align:right" | '''5.8''' |
||
| style="text-align:right" | 1,298 |
| style="text-align:right" | 1,298 |
||
| style="text-align:right" | '''1,376''' |
| style="text-align:right" | '''1,376''' |
||
| Line 3,238: | Line 3,305: | ||
| style="text-align:right" | '''19.6''' |
| style="text-align:right" | '''19.6''' |
||
|- |
|- |
||
| style="text-align:left" | '''Consolidation {{footnote|1= |
| style="text-align:left" | '''Consolidation {{footnote|1=Represents elimination of transactions between Allianz Group entities in different geographic regions.}}''' |
||
| style="text-align:right" | '''-1,007''' |
| style="text-align:right" | '''-1,007''' |
||
| style="text-align:right" | '''-949''' |
| style="text-align:right" | '''-949''' |
||
| Line 3,274: | Line 3,341: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Property-casualty |
|+ Property-casualty breakdown by customer segment for 12 months 2024 and 12 months 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="2" style="text-align:center" | Property- |
! colspan="2" style="text-align:center" | Property-Casualty |
||
! style="text-align:center" | Retail lines {{footnote|1= |
! style="text-align:center" | Retail lines {{footnote|1=Retail including SME and Fleet.}} |
||
! style="text-align:center" | Retail lines |
|||
| ⚫ | |||
! style="text-align:center" | Commercial lines {{footnote|1=Commercial including large corporate, MidCorp, credit insurance, internal and 3rd party reinsurance.}} |
! style="text-align:center" | Commercial lines {{footnote|1=Commercial including large corporate, MidCorp, credit insurance, internal and 3rd party reinsurance.}} |
||
! style="text-align:center" | Commercial lines |
! style="text-align:center" | Commercial lines |
||
! colspan="2" style="text-align:center" | Not allocated |
! colspan="2" style="text-align:center" | Not allocated |
||
|- |
|- |
||
| Line 3,286: | Line 3,353: | ||
! colspan="8" style="text-align:center" | 12M |
! colspan="8" style="text-align:center" | 12M |
||
|- |
|- |
||
| style="text-align:left" | '''Total business volume |
| style="text-align:left" | '''Total business volume {{footnote|1=Total business volume comprises gross premiums written and fee and commission income.}}''' |
||
| style="text-align:right" | '''82,883''' |
| style="text-align:right" | '''82,883''' |
||
| style="text-align:right" | '''86,741''' |
| style="text-align:right" | '''86,741''' |
||
| Line 3,354: | Line 3,421: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ |
|+ Life and health operating profit build-up for fiscal years 2024 and 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
|- |
|- |
||
| style="text-align:left" | '''Total business volume |
| style="text-align:left" | '''Total business volume {{footnote|1=Total business volume comprises statutory gross premiums.}}''' |
||
| style="text-align:right" | '''89,317''' |
| style="text-align:right" | '''89,317''' |
||
| style="text-align:right" | '''92,314''' |
| style="text-align:right" | '''92,314''' |
||
| Line 3,371: | Line 3,438: | ||
| style="text-align:right" | '''523''' |
| style="text-align:right" | '''523''' |
||
|- |
|- |
||
| style="text-align:left" | Variances from claims and expenses |
| style="text-align:left" | Variances from claims and expenses {{footnote|1=Including operating reinsurance result.}} |
||
| style="text-align:right" | '''56''' |
| style="text-align:right" | '''56''' |
||
| style="text-align:right" | '''46''' |
| style="text-align:right" | '''46''' |
||
| Line 3,427: | Line 3,494: | ||
| style="text-align:right" | '''-10''' |
| style="text-align:right" | '''-10''' |
||
|- |
|- |
||
| style="text-align:left" | Other (including tax reclassifications) {{footnote|1= |
| style="text-align:left" | Other (including tax reclassifications) {{footnote|1=Including hyperinflation result.}} |
||
| style="text-align:right" | '''163''' |
| style="text-align:right" | '''163''' |
||
| style="text-align:right" | '''59''' |
| style="text-align:right" | '''59''' |
||
| Line 3,487: | Line 3,554: | ||
| style="text-align:right" | '''3,928''' |
| style="text-align:right" | '''3,928''' |
||
|- |
|- |
||
| style="text-align:left" | '''Core return on |
| style="text-align:left" | '''Core return on equity⁴ (in %) {{footnote|1=For current year periods and prior year periods, the core return on equity for the respective full year is shown.}}''' |
||
| style="text-align:right" | '''16.3''' |
| style="text-align:right" | '''16.3''' |
||
| style="text-align:right" | '''15.2''' |
| style="text-align:right" | '''15.2''' |
||
| Line 3,499: | Line 3,566: | ||
| style="text-align:right" | '''11.7''' |
| style="text-align:right" | '''11.7''' |
||
|- |
|- |
||
| style="text-align:left" | '''Risk adjustment (gross of reinsurance) {{footnote|1= |
| style="text-align:left" | '''Risk adjustment (gross of reinsurance) {{footnote|1=Refers to liability for remaining coverage (LRC).}}''' |
||
| style="text-align:right" | '''4,928''' |
| style="text-align:right" | '''4,928''' |
||
| style="text-align:right" | '''4,836''' |
| style="text-align:right" | '''4,836''' |
||
| Line 3,534: | Line 3,601: | ||
| style="text-align:right" | 3,609 |
| style="text-align:right" | 3,609 |
||
| style="text-align:right" | '''5,382''' |
| style="text-align:right" | '''5,382''' |
||
| style="text-align:right" | |
| style="text-align:right" | 5.7 |
||
| style="text-align:right" | ''' |
| style="text-align:right" | '''5.6''' |
||
| style="text-align:right" | 206 |
| style="text-align:right" | 206 |
||
| style="text-align:right" | '''300''' |
| style="text-align:right" | '''300''' |
||
| Line 3,555: | Line 3,622: | ||
| style="text-align:right" | '''48''' |
| style="text-align:right" | '''48''' |
||
|- |
|- |
||
| style="text-align:left" | Central Europe |
| style="text-align:left" | Central Europe {{footnote|1=Includes the Austrian health business from 01.01.2025.}} |
||
| style="text-align:right" | 1,633 |
| style="text-align:right" | 1,633 |
||
| style="text-align:right" | '''2,074''' |
| style="text-align:right" | '''2,074''' |
||
| Line 3,566: | Line 3,633: | ||
| style="text-align:right" | '''24,697''' |
| style="text-align:right" | '''24,697''' |
||
| style="text-align:right" | '''27,153''' |
| style="text-align:right" | '''27,153''' |
||
| style="text-align:right" | ''' |
| style="text-align:right" | '''5.2''' |
||
| style="text-align:right" | ''' |
| style="text-align:right" | '''5.3''' |
||
| style="text-align:right" | '''1,292''' |
| style="text-align:right" | '''1,292''' |
||
| style="text-align:right" | '''1,429''' |
| style="text-align:right" | '''1,429''' |
||
| Line 3,583: | Line 3,650: | ||
| style="text-align:right" | '''6,871''' |
| style="text-align:right" | '''6,871''' |
||
| style="text-align:right" | 4.6 |
| style="text-align:right" | 4.6 |
||
| style="text-align:right" | ''' |
| style="text-align:right" | '''5.3''' |
||
| style="text-align:right" | 305 |
| style="text-align:right" | 305 |
||
| style="text-align:right" | '''365''' |
| style="text-align:right" | '''365''' |
||
| Line 3,686: | Line 3,753: | ||
| style="text-align:right" | '''81,827''' |
| style="text-align:right" | '''81,827''' |
||
| style="text-align:right" | '''84,682''' |
| style="text-align:right" | '''84,682''' |
||
| style="text-align:right" | ''' |
| style="text-align:right" | '''5.7''' |
||
| style="text-align:right" | ''' |
| style="text-align:right" | '''5.7''' |
||
| style="text-align:right" | '''4,694''' |
| style="text-align:right" | '''4,694''' |
||
| style="text-align:right" | '''4,829''' |
| style="text-align:right" | '''4,829''' |
||
| Line 3,695: | Line 3,762: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Contractual service margin (CSM) |
|+ Contractual service margin (CSM) build-up for 12-month periods 2024 and 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="2" style="text-align:center" | 12M |
! colspan="2" style="text-align:center" | 12M |
||
| Line 3,772: | Line 3,839: | ||
| style="text-align:right" | '''9''' |
| style="text-align:right" | '''9''' |
||
|- |
|- |
||
| style="text-align:left" | Central Europe |
| style="text-align:left" | Central Europe {{footnote|1=Includes the Austrian health business from 01.01.2025.}} |
||
| style="text-align:right" | 456 |
| style="text-align:right" | 456 |
||
| style="text-align:right" | '''605''' |
| style="text-align:right" | '''605''' |
||
| Line 3,912: | Line 3,979: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Contractual service margin (CSM) |
|+ Contractual service margin (CSM) build-up for fourth quarters 2024 and 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | 4Q 24 |
! class="col-s" style="text-align:right" | 4Q 24 |
||
| Line 3,939: | Line 4,006: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Life and health |
|+ Life and health business volume, operating insurance revenue, operating profit, and contractual service margin by region for 12-month periods 2024 and 2025 |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | EUR mn |
! colspan="2" style="text-align:center" | EUR mn |
||
| Line 3,946: | Line 4,013: | ||
|- |
|- |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! |
! style="text-align:center" | Total business volume {{footnote|1=Total business volume comprises statutory gross premiums.}} |
||
! colspan="2" style="text-align:center" | Total business volume |
|||
! colspan="2" style="text-align:center" | Operating insurance revenue |
! colspan="2" style="text-align:center" | Operating insurance revenue |
||
! colspan="2" style="text-align:center" | Operating profit (loss) |
! colspan="2" style="text-align:center" | Operating profit (loss) |
||
! style="text-align:center" | Contractual service margin {{footnote|1= |
! style="text-align:center" | Contractual service margin {{footnote|1=Includes gross CSM of EUR 0.8bn as of 31.12.2024, for UniCredit Allianz Vita S.p.A., which was classified as held for sale in the 3Q 24. Sale has been completed in 2Q 25.}} |
||
! style="text-align:center" | Contractual service margin |
! style="text-align:center" | Contractual service margin |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 3,960: | Line 4,028: | ||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | Internal growth |
! class="col-s" style="text-align:right" | Internal growth {{footnote|1=This reflects the growth of total business volume on an internal basis, adjusted for foreign currency translation and (de-)consolidation effects.}} |
||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
| Line 4,012: | Line 4,080: | ||
| style="text-align:right" | '''1,830''' |
| style="text-align:right" | '''1,830''' |
||
|- |
|- |
||
| style="text-align:left" | Central Europe {{footnote|1=Includes |
| style="text-align:left" | Central Europe {{footnote|1=Includes the Austrian health business from 01.01.2025.}} |
||
| style="text-align:right" | 2,118 |
| style="text-align:right" | 2,118 |
||
| style="text-align:right" | '''2,402''' |
| style="text-align:right" | '''2,402''' |
||
| Line 4,199: | Line 4,267: | ||
| style="text-align:right" | '''1,002''' |
| style="text-align:right" | '''1,002''' |
||
|- |
|- |
||
| style="text-align:left" | '''Consolidation and other {{footnote|1= |
| style="text-align:left" | '''Consolidation and other {{footnote|1=Includes small entities and elimination of transactions between Allianz Group entities in different geographic regions.}}''' |
||
| style="text-align:right" | '''-135''' |
| style="text-align:right" | '''-135''' |
||
| style="text-align:right" | '''-507''' |
| style="text-align:right" | '''-507''' |
||
| Line 4,227: | Line 4,295: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Life and health |
|+ Life and health business volume, operating insurance revenue, operating profit, and contractual service margin by region for fourth quarters 2024 and 2025 |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | EUR mn |
! colspan="2" style="text-align:center" | EUR mn |
||
| Line 4,234: | Line 4,302: | ||
|- |
|- |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! |
! style="text-align:center" | Total business volume {{footnote|1=Total business volume comprises statutory gross premiums.}} |
||
! colspan="2" style="text-align:center" | Total business volume |
|||
! colspan="2" style="text-align:center" | Operating insurance revenue |
! colspan="2" style="text-align:center" | Operating insurance revenue |
||
! colspan="2" style="text-align:center" | Operating profit (loss) |
! colspan="2" style="text-align:center" | Operating profit (loss) |
||
! |
! style="text-align:center" | Contractual service margin {{footnote|1=Includes gross CSM of EUR 0.8bn as of 31.12.2024, for UniCredit Allianz Vita S.p.A., which was classified as held for sale in the 3Q 24. Sale has been completed in 2Q 25.}} |
||
! style="text-align:center" | Contractual service margin |
|||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
| Line 4,252: | Line 4,322: | ||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | Internal growth |
! class="col-s" style="text-align:right" | Internal growth {{footnote|1=This reflects the growth of total business volume on an internal basis, adjusted for foreign currency translation and (de-)consolidation effects.}} |
||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
| Line 4,304: | Line 4,374: | ||
| style="text-align:right" | '''1,830''' |
| style="text-align:right" | '''1,830''' |
||
|- |
|- |
||
| style="text-align:left" | Central Europe |
| style="text-align:left" | Central Europe {{footnote|1=Includes the Austrian health business from 01.01.2025.}} |
||
| style="text-align:right" | 551 |
| style="text-align:right" | 551 |
||
| style="text-align:right" | '''645''' |
| style="text-align:right" | '''645''' |
||
| Line 4,491: | Line 4,561: | ||
| style="text-align:right" | '''1,002''' |
| style="text-align:right" | '''1,002''' |
||
|- |
|- |
||
| style="text-align:left" | '''Consolidation and other {{footnote|1= |
| style="text-align:left" | '''Consolidation and other {{footnote|1=Includes small entities and elimination of transactions between Allianz Group entities in different geographic regions.}}''' |
||
| style="text-align:right" | '''-25''' |
| style="text-align:right" | '''-25''' |
||
| style="text-align:right" | '''-25''' |
| style="text-align:right" | '''-25''' |
||
| Line 4,519: | Line 4,589: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Life and health segment |
|+ Life and health segment operating profit and business volume by product type for 12-month periods 2024 and 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="2" style="text-align:center" | Life/ |
! colspan="2" style="text-align:center" | Life/health segment |
||
! colspan="2" style="text-align:center" | Capital-efficient products |
! colspan="2" style="text-align:center" | Capital-efficient products |
||
! colspan="2" style="text-align:center" | Unit-linked without guarantees |
! colspan="2" style="text-align:center" | Unit-linked without guarantees |
||
| Line 4,528: | Line 4,598: | ||
|- |
|- |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! |
! class="col-s" style="text-align:right" | 12M |
||
| ⚫ | |||
! colspan="8" style="text-align:center" | 12M |
|||
|- |
|- |
||
| style="text-align:left" | Release CSM |
| style="text-align:left" | Release CSM |
||
| Line 4,554: | Line 4,626: | ||
| style="text-align:right" | 108 |
| style="text-align:right" | 108 |
||
|- |
|- |
||
| style="text-align:left" | Variances from claims and expenses |
| style="text-align:left" | Variances from claims and expenses {{footnote|1=Including operating reinsurance result.}} |
||
| style="text-align:right" | 56 |
| style="text-align:right" | 56 |
||
| style="text-align:right" | 46 |
| style="text-align:right" | 46 |
||
| Line 4,626: | Line 4,698: | ||
| style="text-align:right" | '''1,507''' |
| style="text-align:right" | '''1,507''' |
||
|- |
|- |
||
| style="text-align:left" | '''Total business volume |
| style="text-align:left" | '''Total business volume {{footnote|1=Total business volume comprises statutory gross premiums.}}''' |
||
| style="text-align:right" | '''89,317''' |
| style="text-align:right" | '''89,317''' |
||
| style="text-align:right" | '''92,314''' |
| style="text-align:right" | '''92,314''' |
||
| Line 4,650: | Line 4,722: | ||
| style="text-align:right" | '''5,644''' |
| style="text-align:right" | '''5,644''' |
||
|- |
|- |
||
| style="text-align:left" | '''Contractual service margin (gross) |
| style="text-align:left" | '''Contractual service margin (gross) {{footnote|1=Includes gross CSM of EUR 0.8bn as of 31.12.2024, for UniCredit Allianz Vita S.p.A., which was classified as held for sale in the 3Q 24. Sale has been completed in 2Q 25.}}''' |
||
| style="text-align:right" | '''55,571''' |
| style="text-align:right" | '''55,571''' |
||
| style="text-align:right" | '''55,703''' |
| style="text-align:right" | '''55,703''' |
||
| Line 4,662: | Line 4,734: | ||
| style="text-align:right" | '''15,058''' |
| style="text-align:right" | '''15,058''' |
||
|- |
|- |
||
| style="text-align:left" | '''PVFCF {{footnote|1=Refers to liability for remaining coverage (LRC).}}''' |
| style="text-align:left" | '''PVFCF {{footnote|1=Refers to liability for remaining coverage (LRC). Includes gross PVFCF of 21.2bn as of 31.12.2024, for UniCredit Allianz Vita S.p.A., which was classified as held for sale in the 3Q 24. Sale has been completed in 2Q 25.}}''' |
||
| style="text-align:right" | '''649,968''' |
| style="text-align:right" | '''649,968''' |
||
| style="text-align:right" | '''633,941''' |
| style="text-align:right" | '''633,941''' |
||
| Line 4,718: | Line 4,790: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Asset management |
|+ Asset management income statement for fiscal years 2024 and 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 4,731: | Line 4,803: | ||
| style="text-align:right" | '''8,408''' |
| style="text-align:right" | '''8,408''' |
||
|- |
|- |
||
| style="text-align:left; padding-left:1.5em" | Thereof: net fee and commission income excl. performance fees |
| style="text-align:left; padding-left:1.5em" | Thereof: net fee and commission income excl. performance fees {{footnote|1=Excluding performance fees and other income.}} |
||
| style="text-align:right" | '''7,640''' |
| style="text-align:right" | '''7,640''' |
||
| style="text-align:right" | '''8,007''' |
| style="text-align:right" | '''8,007''' |
||
| Line 4,751: | Line 4,823: | ||
| style="text-align:right" | '''-5,162''' |
| style="text-align:right" | '''-5,162''' |
||
|- |
|- |
||
| style="text-align:left" | '''Operating profit |
| style="text-align:left" | '''Operating profit {{footnote|1=Includes operating result from PIMCO, AllianzGI and other entities.}}''' |
||
| style="text-align:right" | '''3,239''' |
| style="text-align:right" | '''3,239''' |
||
| style="text-align:right" | '''3,345''' |
| style="text-align:right" | '''3,345''' |
||
| Line 4,795: | Line 4,867: | ||
| style="text-align:right" | '''-2''' |
| style="text-align:right" | '''-2''' |
||
|- |
|- |
||
| ⚫ | | style="text-align:left" | Other {{footnote|1=Includes mainly reclassification effects from operating to non-operating result related to a disposal of an investment as of 30.06.2025 and, if applicable, acquisition-related expenses, income taxes related incidental benefits/expenses and litigation expenses.}} |
||
| ⚫ | |||
| style="text-align:right" | '''8''' |
| style="text-align:right" | '''8''' |
||
| style="text-align:right" | '''-29''' |
| style="text-align:right" | '''-29''' |
||
| Line 4,879: | Line 4,951: | ||
| style="text-align:right" | '''41.2''' |
| style="text-align:right" | '''41.2''' |
||
|- |
|- |
||
| style="text-align:left" | '''Core return on equity⁴ (in %)''' |
| style="text-align:left" | '''Core return on equity⁴ (in %) {{footnote|1=For current year periods and prior year periods, the core return on equity for the respective full year is shown.}}''' |
||
| style="text-align:right" | '''21.5''' |
| style="text-align:right" | '''21.5''' |
||
| style="text-align:right" | '''22.3''' |
| style="text-align:right" | '''22.3''' |
||
| Line 4,885: | Line 4,957: | ||
</div> |
</div> |
||
== AM |
== AM AUM == |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Assets under management breakdown by |
|+ Assets under management breakdown by type, asset class, and region for fiscal years 2024 and 2025 |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 4,954: | Line 5,026: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Third-party net flows breakdown by |
|+ Third-party net flows breakdown by PIMCO and AllianzGI for fiscal years 2024 and 2025 |
||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 4,977: | Line 5,049: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Operating and non-operating items for corporate and other |
|+ Operating profit and non-operating items build-up for corporate and other for fiscal years 2024 and 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 5,030: | Line 5,102: | ||
| style="text-align:right" | '''-339''' |
| style="text-align:right" | '''-339''' |
||
|- |
|- |
||
| style="text-align:left; padding-left:1.5em" | Thereof: |
| style="text-align:left; padding-left:1.5em" | Thereof: non-operating market movements |
||
| style="text-align:right" | '''33''' |
| style="text-align:right" | '''33''' |
||
| style="text-align:right" | '''-62''' |
| style="text-align:right" | '''-62''' |
||
| Line 5,046: | Line 5,118: | ||
| style="text-align:right" | '''-16''' |
| style="text-align:right" | '''-16''' |
||
|- |
|- |
||
| style="text-align:left; padding-left:1.5em" | Thereof: |
| style="text-align:left; padding-left:1.5em" | Thereof: amortization of intangible assets from business combinations |
||
| style="text-align:right" | '''-11''' |
| style="text-align:right" | '''-11''' |
||
| style="text-align:right" | '''-14''' |
| style="text-align:right" | '''-14''' |
||
| Line 5,116: | Line 5,188: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Consolidation of operating and non-operating items for fiscal years 2024 and 2025 |
|+ Consolidation of operating profit and non-operating items for fiscal years 2024 and 2025 |
||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
|- |
|- |
||
| style="text-align:left" | '''Total business volume |
| style="text-align:left" | '''Total business volume {{footnote|1=Total business volume comprises gross premiums written and fee and commission income in Property-Casualty, statutory gross premiums in Life/Health, and operating revenues in Asset Management.}}''' |
||
| style="text-align:right" | '''-746''' |
| style="text-align:right" | '''-746''' |
||
| style="text-align:right" | '''-623''' |
| style="text-align:right" | '''-623''' |
||
| Line 5,149: | Line 5,221: | ||
| style="text-align:right" | '''1''' |
| style="text-align:right" | '''1''' |
||
|- |
|- |
||
| style="text-align:left; padding-left:1.5em" | Thereof: |
| style="text-align:left; padding-left:1.5em" | Thereof: non-operating market movements |
||
| style="text-align:right" | '''1''' |
| style="text-align:right" | '''1''' |
||
| style="text-align:right" | '''1''' |
| style="text-align:right" | '''1''' |
||
| Line 5,165: | Line 5,237: | ||
| style="text-align:right" | '''0''' |
| style="text-align:right" | '''0''' |
||
|- |
|- |
||
| style="text-align:left; padding-left:1.5em" | Thereof: |
| style="text-align:left; padding-left:1.5em" | Thereof: amortization of intangible assets from business combinations |
||
| style="text-align:right" | '''0''' |
| style="text-align:right" | '''0''' |
||
| style="text-align:right" | '''0''' |
| style="text-align:right" | '''0''' |
||
| Line 5,225: | Line 5,297: | ||
| style="text-align:right" | '''-1''' |
| style="text-align:right" | '''-1''' |
||
|- |
|- |
||
| style="text-align:left" | '''Thereof: |
| style="text-align:left" | '''Thereof: shareholders' core net income (loss)''' |
||
| style="text-align:right" | '''-1''' |
| style="text-align:right" | '''-1''' |
||
| style="text-align:right" | '''-1''' |
| style="text-align:right" | '''-1''' |
||
Latest revision as of 22:57, 13 June 2026
| Document info | |
|---|---|
| Organization | Allianz |
| Year | 2025 |
| Period | FY |
| Period label | FY25 |
| Document type | Financial supplement |
| Language | English |
| Source | Original URL |
| Archive | .md file |
Allianz Group FY25 financial supplement.
Market Data
| Spot | ||||
|---|---|---|---|---|
| — | 30.06.2024 | 31.12.2024 | 30.06.2025 | 31.12.2025 |
| USD | 1.0717 | 1.0355 | 1.1739 | 1.1744 |
| CHF | 0.9630 | 0.9385 | 0.9344 | 0.9305 |
| GBP | 0.8478 | 0.8268 | 0.8566 | 0.8731 |
| AUD | 1.6048 | 1.6724 | 1.7912 | 1.7612 |
| Average | ||
|---|---|---|
| — | 2024 | 2025 |
| USD | 1.0820 | 1.1308 |
| CHF | 0.9526 | 0.9371 |
| GBP | 0.8466 | 0.8570 |
| AUD | 1.6399 | 1.7522 |
| 31.12.2024 | 31.03.2025 | |||||
|---|---|---|---|---|---|---|
| — | 1 year | 5 years | 10 years | 20 years | 30 years | 1 year |
| Unit-linked contracts | — | — | — | — | — | — |
| EUR | 2.27 | 2.18 | 2.30 | 2.29 | 2.38 | 2.18 |
| USD | 4.09 | 3.94 | 3.99 | 4.02 | 3.80 | 3.90 |
| Immediate fixed annuity and P/C liability for incurred claims | — | — | — | — | — | — |
| EUR | 2.55 | 2.46 | 2.58 | 2.58 | 2.62 | 2.45 |
| USD | 4.64 | 4.49 | 4.53 | 4.57 | 4.33 | 4.59 |
| Traditional participating and other insurance contracts (footnote: Ranges in valuation rates reflect different liquidity characteristics of insurance portfolios in a given currency.) | — | — | — | — | — | — |
| EUR | 2.47 - 3.11 | 2.38 - 3.02 | 2.50 - 3.14 | 2.49 - 3.13 | 2.55 - 3.08 | 2.36 - 3.00 |
| USD | 5.34 - 5.41 | 5.19 - 5.25 | 5.24 - 5.30 | 5.27 - 5.34 | 5.00 - 5.06 | 5.19 - 5.37 |
| 30.06.2025 | 30.09.2025 | |||||
|---|---|---|---|---|---|---|
| — | 1 year | 5 years | 10 years | 20 years | 30 years | 1 year |
| Unit-linked contracts | — | — | — | — | — | — |
| EUR | 1.93 | 2.20 | 2.54 | 2.76 | 2.82 | 2.05 |
| USD | 3.80 | 3.37 | 3.65 | 3.96 | 3.87 | 3.58 |
| Immediate fixed annuity and P/C liability for incurred claims | — | — | — | — | — | — |
| EUR | 2.19 | 2.45 | 2.79 | 3.01 | 3.04 | 2.26 |
| USD | 4.51 | 4.09 | 4.36 | 4.67 | 4.54 | 4.17 |
| Traditional participating and other insurance contracts³ | — | — | — | — | — | — |
| EUR | 1.93 - 2.68 | 2.20 - 2.94 | 2.54 - 3.28 | 2.76 - 3.51 | 2.82 - 3.47 | 2.05 - 2.75 |
| USD | 5.09 - 5.29 | 4.67 - 4.87 | 4.95 - 5.15 | 5.25 - 5.45 | 5.10 - 5.29 | 4.69 - 4.95 |
| 31.12.2025 | |||||
|---|---|---|---|---|---|
| — | 1 year | 5 years | 10 years | 20 years | 30 years |
| Unit-linked contracts | — | — | — | — | — |
| EUR | 2.09 | 2.49 | 2.86 | 3.20 | 3.25 |
| USD | 3.37 | 3.41 | 3.77 | 4.19 | 4.14 |
| Immediate fixed annuity and P/C liability for incurred claims | — | — | — | — | — |
| EUR | 2.27 | 2.66 | 3.04 | 3.37 | 3.40 |
| USD | 3.93 | 3.97 | 4.32 | 4.75 | 4.67 |
| Traditional participating and other insurance contracts³ | — | — | — | — | — |
| EUR | 2.09 - 2.74 | 2.49 - 3.14 | 2.86 - 3.51 | 3.20 - 3.84 | 3.25 - 3.80 |
| USD | 4.40 - 4.63 | 4.44 - 4.67 | 4.79 - 5.02 | 5.22 - 5.44 | 5.11 - 5.33 |
Balance Sheet
| EUR million | ||||
|---|---|---|---|---|
| — | 30.06.2024 | 31.12.2024 | 30.06.2025 | 31.12.2025 |
| Cash and cash equivalents | 28,058 | 31,637 | 33,886 | 29,854 |
| Investments | 729,065 | 752,815 | 732,606 | 753,487 |
| Financial assets for unit-linked contracts | 160,465 | 146,470 | 145,831 | 158,203 |
| Insurance contract assets | 88 | 142 | 214 | 223 |
| Reinsurance contract assets | 25,627 | 28,770 | 26,059 | 27,797 |
| Deferred tax assets | 6,305 | 6,055 | 5,354 | 5,161 |
| Other assets | 29,744 | 59,564 | 30,550 | 30,928 |
| Intangible assets | 19,003 | 19,126 | 18,384 | 18,623 |
| Total assets | 998,354 | 1,044,578 | 992,884 | 1,024,276 |
| EUR million | ||||
|---|---|---|---|---|
| — | 30.06.2024 | 31.12.2024 | 30.06.2025 | 31.12.2025 |
| Cash and cash equivalents | 5,602 | 7,322 | 6,749 | 6,101 |
| Investments | 119,869 | 121,318 | 112,410 | 114,015 |
| Financial assets for unit-linked contracts | 0 | 0 | 0 | 0 |
| Insurance contract assets | 0 | 18 | 63 | 34 |
| Reinsurance contract assets | 11,390 | 14,366 | 13,718 | 15,601 |
| Deferred tax assets | 1,650 | 1,829 | 1,575 | 1,353 |
| Other assets | 25,202 | 26,878 | 27,354 | 26,500 |
| Intangible assets | 6,518 | 6,450 | 6,220 | 6,475 |
| Total assets | 170,232 | 178,180 | 168,088 | 170,080 |
| EUR million | ||||
|---|---|---|---|---|
| — | 30.06.2024 | 31.12.2024 | 30.06.2025 | 31.12.2025 |
| Cash and cash equivalents | 16,501 | 17,364 | 20,056 | 18,641 |
| Investments | 582,175 | 598,409 | 586,224 | 605,446 |
| Financial assets for unit-linked contracts | 160,465 | 146,470 | 145,831 | 158,203 |
| Insurance contract assets | 88 | 124 | 151 | 188 |
| Reinsurance contract assets | 14,311 | 14,546 | 12,471 | 12,284 |
| Deferred tax assets | 5,006 | 12,359 | 12,203 | 11,476 |
| Other assets | 15,452 | 47,166 | 19,088 | 18,304 |
| Intangible assets | 4,609 | 4,633 | 4,588 | 4,585 |
| Total assets | 798,606 | 841,071 | 800,613 | 829,128 |
| EUR million | ||||
|---|---|---|---|---|
| — | 30.06.2024 | 31.12.2024 | 30.06.2025 | 31.12.2025 |
| Cash and cash equivalents | 1,326 | 1,195 | 975 | 1,064 |
| Investments | 1,169 | 1,340 | 1,263 | 1,472 |
| Financial assets for unit-linked contracts | 0 | 0 | 0 | 0 |
| Insurance contract assets | 0 | 0 | 0 | 0 |
| Reinsurance contract assets | 0 | 0 | 0 | 0 |
| Deferred tax assets | 266 | 242 | 264 | 260 |
| Other assets | 5,845 | 6,431 | 5,870 | 6,563 |
| Intangible assets | 7,582 | 7,708 | 7,257 | 7,251 |
| Total assets | 16,188 | 16,917 | 15,629 | 16,611 |
| EUR million | ||||
|---|---|---|---|---|
| — | 30.06.2024 | 31.12.2024 | 30.06.2025 | 31.12.2025 |
| Cash and cash equivalents | 4,922 | 5,982 | 6,250 | 4,214 |
| Investments | 126,338 | 132,690 | 134,567 | 134,224 |
| Financial assets for unit-linked contracts | 0 | 0 | 0 | 0 |
| Insurance contract assets | 0 | 0 | 0 | 0 |
| Reinsurance contract assets | 0 | 0 | 0 | 0 |
| Deferred tax assets | 1,489 | 971 | 819 | 791 |
| Other assets | 8,769 | 10,418 | 8,761 | 10,188 |
| Intangible assets | 290 | 331 | 316 | 307 |
| Total assets | 141,809 | 150,392 | 150,713 | 149,724 |
| EUR million | ||||
|---|---|---|---|---|
| — | 30.06.2024 | 31.12.2024 | 30.06.2025 | 31.12.2025 |
| Cash and cash equivalents | -293 | -227 | -144 | -166 |
| Investments | -100,486 | -100,941 | -101,858 | -101,670 |
| Financial assets for unit-linked contracts | 0 | 0 | 0 | 0 |
| Insurance contract assets | 0 | 0 | 0 | 0 |
| Reinsurance contract assets | -75 | -142 | -130 | -89 |
| Deferred tax assets | -2,106 | -9,345 | -9,508 | -8,718 |
| Other assets | -25,525 | -31,329 | -30,523 | -30,627 |
| Intangible assets | 3 | 3 | 3 | 3 |
| Total assets | -128,481 | -141,983 | -142,158 | -141,267 |
| EUR million | 30.06.2024 | 31.12.2024 | 30.06.2025 | 31.12.2025 |
|---|---|---|---|---|
| Financial liabilities | 62,690 | 66,137 | 64,717 | 66,291 |
| Insurance contract liabilities | 789,512 | 800,511 | 780,496 | 800,677 |
| Reinsurance contract liabilities | 267 | 316 | 434 | 497 |
| Investment contract liabilities | 50,252 | 44,553 | 46,328 | 50,550 |
| Deferred tax liabilities | 2,283 | 2,257 | 2,231 | 2,436 |
| Other liabilities | 34,541 | 66,728 | 38,166 | 37,477 |
| Total liabilities | 939,544 | 980,502 | 932,372 | 957,928 |
| Shareholders' equity | 55,511 | 60,287 | 57,195 | 62,722 |
| Issued capital | 1,170 | 1,170 | 1,170 | 1,170 |
| Additional paid-in capital | 27,732 | 27,732 | 27,732 | 27,732 |
| Undated subordinated bonds | 4,833 | 4,915 | 4,630 | 4,629 |
| Retained earnings | 29,073 | 33,316 | 31,739 | 36,243 |
| Foreign currency translation adjustments | -2,379 | -1,614 | -4,473 | -4,512 |
| Net unrealized gains and losses | -4,917 | -5,232 | -3,602 | -2,540 |
| Non-controlling interests | 3,299 | 3,789 | 3,317 | 3,627 |
| Total equity | 58,810 | 64,076 | 60,512 | 66,349 |
| Total liabilities and equity | 998,354 | 1,044,578 | 992,884 | 1,024,276 |
| EUR million | 30.06.2024 | 31.12.2024 | 30.06.2025 | 31.12.2025 |
|---|---|---|---|---|
| Financial liabilities | 1,983 | 2,996 | 3,322 | 1,881 |
| Insurance contract liabilities | 99,699 | 102,436 | 95,523 | 96,308 |
| Reinsurance contract liabilities | 113 | 124 | 227 | 261 |
| Investment contract liabilities | 0 | 0 | 0 | 0 |
| Deferred tax liabilities | 1,752 | 2,274 | 2,072 | 2,233 |
| Other liabilities | 16,605 | 18,070 | 16,654 | 17,708 |
| Total liabilities | 120,152 | 125,901 | 117,799 | 118,390 |
| Shareholders' equity | 48,595 | 50,632 | 48,664 | 49,946 |
| Non-controlling interests | 1,485 | 1,647 | 1,624 | 1,743 |
| Total equity | 50,080 | 52,280 | 50,289 | 51,689 |
| Total liabilities and equity | 170,232 | 178,180 | 168,088 | 170,080 |
| EUR million | 30.06.2024 | 31.12.2024 | 30.06.2025 | 31.12.2025 |
|---|---|---|---|---|
| Financial liabilities | 25,470 | 26,608 | 24,529 | 28,398 |
| Insurance contract liabilities | 689,908 | 698,221 | 685,064 | 704,423 |
| Reinsurance contract liabilities | 154 | 191 | 207 | 235 |
| Investment contract liabilities | 50,252 | 44,553 | 46,328 | 50,550 |
| Deferred tax liabilities | 2,064 | 8,732 | 8,903 | 8,022 |
| Other liabilities | 8,329 | 39,226 | 9,658 | 9,266 |
| Total liabilities | 776,178 | 817,531 | 774,689 | 800,894 |
| Shareholders' equity | 20,779 | 21,601 | 24,449 | 26,701 |
| Non-controlling interests | 1,650 | 1,939 | 1,475 | 1,533 |
| Total equity | 22,428 | 23,540 | 25,924 | 28,234 |
| Total liabilities and equity | 798,606 | 841,071 | 800,613 | 829,128 |
| EUR million | 30.06.2024 | 31.12.2024 | 30.06.2025 | 31.12.2025 |
|---|---|---|---|---|
| Financial liabilities | 116 | 108 | 4 | 169 |
| Insurance contract liabilities | 0 | 0 | 0 | 0 |
| Reinsurance contract liabilities | 0 | 0 | 0 | 0 |
| Investment contract liabilities | 0 | 0 | 0 | 0 |
| Deferred tax liabilities | 135 | 156 | 142 | 140 |
| Other liabilities | 5,577 | 6,065 | 5,453 | 6,206 |
| Total liabilities | 5,828 | 6,329 | 5,600 | 6,516 |
| Shareholders' equity | 10,246 | 10,461 | 9,913 | 9,976 |
| Non-controlling interests | 114 | 127 | 117 | 120 |
| Total equity | 10,360 | 10,588 | 10,030 | 10,095 |
| Total liabilities and equity | 16,188 | 16,917 | 15,629 | 16,611 |
| EUR million | 30.06.2024 | 31.12.2024 | 30.06.2025 | 31.12.2025 |
|---|---|---|---|---|
| Financial liabilities | 42,704 | 44,597 | 44,464 | 42,706 |
| Insurance contract liabilities | 0 | 0 | 0 | 0 |
| Reinsurance contract liabilities | 0 | 0 | 0 | 0 |
| Investment contract liabilities | 0 | 0 | 0 | 0 |
| Deferred tax liabilities | 444 | 443 | 625 | 762 |
| Other liabilities | 29,499 | 34,603 | 36,878 | 34,862 |
| Total liabilities | 72,648 | 79,643 | 81,967 | 78,330 |
| Shareholders' equity | 68,890 | 70,455 | 68,423 | 70,945 |
| Non-controlling interests | 271 | 294 | 323 | 449 |
| Total equity | 69,161 | 70,749 | 68,745 | 71,395 |
| Total liabilities and equity | 141,809 | 150,392 | 150,713 | 149,724 |
| EUR million | 30.06.2024 | 31.12.2024 | 30.06.2025 | 31.12.2025 |
|---|---|---|---|---|
| Financial liabilities | -7,583 | -8,172 | -7,603 | -6,864 |
| Insurance contract liabilities | -96 | -145 | -92 | -54 |
| Reinsurance contract liabilities | 0 | 0 | 0 | 0 |
| Investment contract liabilities | 0 | 0 | 0 | 0 |
| Deferred tax liabilities | -2,113 | -9,348 | -9,511 | -8,721 |
| Other liabilities | -25,470 | -31,235 | -30,478 | -30,564 |
| Total liabilities | -35,262 | -48,901 | -47,683 | -46,202 |
| Shareholders' equity | -92,999 | -92,862 | -94,254 | -94,846 |
| Non-controlling interests | -221 | -219 | -221 | -219 |
| Total equity | -93,219 | -93,081 | -94,475 | -95,064 |
| Total liabilities and equity | -128,481 | -141,983 | -142,158 | -141,267 |
| EUR million | Allianz group |
|---|---|
| — | 12M |
| Opening balance | 60,287 |
| Total comprehensive income | 10,517 |
| Thereof: shareholders' net income | 10,775 |
| Purchase, sale, use and cancellation of treasury shares | -1,994 |
| Changes in scope of consolidation | 0 |
| Changes in ownership interests in subsidiaries | -34 |
| Capital increases and decreases | 0 |
| Other changes | 29 |
| Dividends paid | -5,924 |
| Other distributions | -158 |
| Closing balance | 62,722 |
| EUR million | As of 31.12.2025 | |
|---|---|---|
| — | Impact | S/h equity |
| Shareholders' equity | — | 62.7 |
| Equity markets +30% | 4% | 65.3 |
| Equity markets -30% | -5% | 59.5 |
| Interest rates +50bps | -1% | 62.0 |
| Interest rates -50bps | 1% | 63.4 |
| Credit spread on government bonds +50bps | -1% | 61.8 |
| Credit spread on non-government bonds +50bps | -1% | 62.2 |
Solvency II
| EUR billion | 4Q 25 | 12M | ||
|---|---|---|---|---|
| — | Own funds | SCR | SII ratio / impact | |
| Opening balance | 94.7 | 93.2 | 44.7 | 209% |
| Regulatory / model changes | -1.1 | -1.0 | -2.0 | 7%-p |
| Operating SII earnings / business evolution� (footnote: Operating SII earnings after tax/before dividend.) | 3.1 | 13.0 | 1.0 | 25%-p |
| Property-casualty | 1.6 | 6.8 | — | — |
| Life/health | 1.1 | 4.9 | — | — |
| Asset management | 0.7 | 2.3 | — | — |
| Corporate and other | -0.3 | -1.0 | — | — |
| Market impact� (footnote: For SCR including cross effects and policyholder participation.) | 1.1 | -0.2 | -0.8 | 4%-p |
| Dividends and share buy-back | -2.1 | -8.5 | 0.0 | -20%-p |
| Management actions, debt and other� (footnote: Other effects on SCR include diversification effects.) | -1.2 | -2.0 | 0.4 | -6%-p |
| Closing balance | 94.5 | 94.5 | 43.3 | 218% |
| Opening balance incl. transitionals | 0.0 | #REF! | #REF! | n/a |
| Closing balance incl. transitionals | 0.0 | #REF! | #REF! | n/a |
| EUR billion | As of 31.12.2025 | |
|---|---|---|
| — | Impact | SII ratio |
| Solvency II ratio | — | 218% |
| Equity markets +30% | 10%-p | 229% |
| Equity markets -30% | -13%-p | 205% |
| Equity markets (traded equities only) +30% | 4%-p | 222% |
| Equity markets (traded equities only) -30% | -4%-p | 214% |
| Interest rates +50bps | 0%-p | 219% |
| Interest rates -50bps | -1%-p | 218% |
| Credit spread on government bonds +50bps | -4%-p | 214% |
| Credit spread on non-government bonds +50bps | 0%-p | 219% |
| Combined scenario�⁵ (IR -50bps, CS +50bps, EQ -30%) (footnote: Including cross effects.) | -22%-p | 196% |
Asset Allocation
| EUR billion | Property-Casualty | Life/Health | Asset Management | Corporate and Other | Consolidation | Allianz Group | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 31.12.2024 | 31.12.2025 | 31.12.2024 | 31.12.2025 | 31.12.2024 | 31.12.2025 | 31.12.2024 | 31.12.2025 | 31.12.2024 | 31.12.2025 | 31.12.2024 | 31.12.2025 |
| Net cash investments� (footnote: Net of liabilities from securities lending and including liabilities from cash pooling.) | 11.4 | 9.2 | 20.5 | 20.3 | 2.5 | 2.3 | -8.0 | -9.2 | 0.1 | -0.1 | 26.6 | 22.5 |
| Equities excluding affiliates | 4.0 | 3.0 | 41.8 | 43.6 | 0.7 | 0.7 | 2.9 | 3.2 | 0.0 | 0.0 | 49.4 | 50.5 |
| Equities carried at fair value through P&L | 0.1 | 0.0 | 0.4 | 0.4 | 0.0 | 0.0 | 0.3 | 0.3 | 0.0 | 0.0 | 0.8 | 0.9 |
| Equities carried at fair value through OCI | 1.0 | 0.9 | 22.6 | 25.6 | 0.7 | 0.6 | 2.1 | 2.6 | 0.0 | 0.0 | 26.3 | 29.7 |
| Equities associates/joint ventures | 3.0 | 2.1 | 18.8 | 17.5 | 0.1 | 0.1 | 0.5 | 0.3 | 0.0 | 0.0 | 22.3 | 20.0 |
| Debt securities | 92.4 | 89.6 | 443.9 | 441.7 | 0.4 | 0.3 | 45.0 | 46.3 | -7.6 | -6.5 | 574.1 | 571.3 |
| Investment funds | 8.3 | 6.8 | 72.9 | 73.5 | 0.2 | 0.4 | 1.0 | 0.9 | 0.0 | 0.0 | 82.5 | 81.6 |
| Equity funds | 2.7 | 2.2 | 27.7 | 26.6 | 0.0 | 0.0 | 0.8 | 0.6 | 0.0 | 0.0 | 31.2 | 29.4 |
| Debt funds | 3.3 | 2.9 | 23.6 | 25.8 | 0.1 | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 27.1 | 29.1 |
| Real estate funds | 1.3 | 0.9 | 11.7 | 10.9 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 13.0 | 11.8 |
| Other funds | 1.1 | 0.8 | 9.9 | 10.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 11.2 | 11.2 |
| Derivatives� (footnote: Net of liabilities.) | -0.2 | 0.2 | 3.6 | 9.8 | 0.0 | 0.0 | 0.0 | -0.2 | 0.6 | 0.7 | 4.0 | 10.6 |
| Other | 4.6 | 3.7 | 24.5 | 22.7 | 0.0 | 0.0 | 1.2 | 1.2 | 0.0 | 0.0 | 30.4 | 27.6 |
| Real estate� (footnote: Excludes real estate held for own use measured at amortized cost.) | 3.9 | 3.2 | 19.6 | 18.9 | 0.0 | 0.0 | 0.8 | 0.8 | 0.0 | 0.0 | 24.3 | 23.0 |
| Fixed assets of alternative investments | 0.5 | 0.4 | 2.2 | 2.6 | 0.0 | 0.0 | 0.2 | 0.3 | 0.0 | 0.0 | 2.9 | 3.3 |
| Other investments | 0.2 | 0.0 | 2.8 | 1.2 | 0.0 | 0.0 | 0.2 | 0.1 | 0.0 | 0.0 | 3.2 | 1.3 |
| Group/segment financial assets excluding affiliates | 120.6 | 112.4 | 607.3 | 611.6 | 3.8 | 3.8 | 42.2 | 42.3 | -6.9 | -5.9 | 767.0 | 764.2 |
| Affiliates | 11.5 | 10.4 | 0.1 | 2.8 | 0.0 | 0.0 | 81.5 | 81.8 | -93.1 | -95.1 | 0.0 | 0.0 |
| Group/segment financial assets including affiliates | 132.0 | 122.8 | 607.4 | 614.4 | 3.8 | 3.8 | 123.6 | 124.1 | -100.0 | -101.0 | 767.0 | 764.2 |
Allianz Group – CSM
| 12M | |||
|---|---|---|---|
| EUR million | Life/Health | Property-Casualty | Allianz group� (footnote: Life/Health and Property-Casualty figures don't add up due to consolidation effects.) |
| Opening gross CSM� (footnote: Life/Health and Group include gross CSM of EUR 0.8bn as of 31.12.2024 and 01.01.2025 for UniCredit Allianz Vita S.p.A., which was classified as held for sale in the 3Q 24. Effective 01.01.2025, the German APR and the Austrian health businesses have been transferred from the Property-Casualty segment to the Life/Health segment resulting in a EUR 1.2bn shift in the gross CSM opening balance.) | 56,789 | 64 | 56,851 |
| Closing gross CSM | 55,703 | 202 | 55,897 |
| Present value of non-attributable expenses | — | — | -7,087 |
| Reinsurance | — | — | -1,411 |
| Non-controlling interests | — | — | -898 |
| Taxes | — | — | -11,121 |
| Closing net CSM | — | — | 35,379 |
| EUR million | Life/Health |
|---|---|
| — | 12M |
| Opening gross CSM�² | 56,789 |
| CSM@inception | 5,419 |
| Expected in-force return | 2,972 |
| Economic variances (incl. F/X) | -1,924 |
| Non-economic variances and assumption changes | -1,310 |
| CSM release | -5,440 |
| Change in scope� (footnote: The change in scope refers to the sale of UniCredit Allianz Vita S.p.A., which was completed in 2Q 25.) | -802 |
| Closing gross CSM | 55,703 |
| EUR million | Life/health | |
|---|---|---|
| — | Impact | Gross CSM |
| Closing gross CSM | — | 55.7 |
| Equity markets +30% | 7% | 59.5 |
| Equity markets -30% | -8% | 51.4 |
| Interest rate (SII non-parallel) +50bps | -1% | 54.9 |
| Interest rate (SII non-parallel) -50bps | 1% | 56.4 |
| Credit spread on government bonds +50bps | -1% | 54.9 |
| Credit spread on non-government bonds +50bps | -1% | 55.1 |
Allianz Group
| EUR million | 2024 | 2025 |
|---|---|---|
| Total business volume (footnote: Total business volume comprises gross premiums written and fee and commission income in Property-Casualty, statutory gross premiums in Life/Health, and operating revenues in Asset Management.) | 179,778 | 186,938 |
| Operating insurance service result | — | — |
| Operating insurance revenue | 97,675 | 102,635 |
| Claims and benefits | -61,775 | -63,920 |
| Operating acquisition and administrative expenses | -24,011 | -24,907 |
| Operating reinsurance result | -3,130 | -3,277 |
| Other insurance service result | 732 | 431 |
| Subtotal | 9,491 | 10,961 |
| Operating investment result | — | — |
| Operating net investment income, excluding interest expenses from external debt | 37,001 | 30,134 |
| Finance income (expenses) from insurance contracts issued (net) | -32,567 | -26,376 |
| Finance income (expenses) from reinsurance contracts held (net) | 416 | 749 |
| Subtotal | 4,850 | 4,507 |
| Operating result from investment contracts | 284 | 273 |
| Operating fee and commission result | 7,957 | 8,304 |
| Operating other result | -6,559 | -6,670 |
| Operating profit | 16,023 | 17,374 |
| Non-operating items | — | — |
| Realized gains/losses (net) | -168 | 643 |
| Expected credit loss and impairments (net) | -48 | -53 |
| Result from assets and liabilities measured at fair value incl. derivatives | -227 | -631 |
| Thereof: non-operating market movements | 92 | -303 |
| Interest expenses from external debt | -762 | -758 |
| Restructuring and integration expenses | -669 | -708 |
| Amortization of intangible assets | -282 | -271 |
| Thereof: amortization of intangible assets from business combinations | -102 | -97 |
| Other (footnote: Including hyperinflation result, tax reclassifications from the Life/Health segment, and reclassification impacts from the Asset Management segment.) | 149 | -136 |
| Subtotal | -2,007 | -1,914 |
| Income (loss) before income taxes | 14,016 | 15,460 |
| Income taxes | -3,476 | -4,030 |
| Net income (loss) | 10,540 | 11,430 |
| Net income (loss) attributable to: | — | — |
| Non-controlling interests | 609 | 655 |
| Shareholders | 9,931 | 10,775 |
| Income (loss) before income taxes | 14,016 | 15,460 |
| Adjustment for non-operating market movements | -92 | 303 |
| Adjustment for amortization of intangible assets from business combinations | 102 | 97 |
| Core income (loss) before income taxes | 14,026 | 15,860 |
| Income taxes related to core income | -3,521 | -4,078 |
| Core net income (loss) | 10,505 | 11,781 |
| thereof: Shareholders' core net income (loss) | 10,017 | 11,113 |
| Core return on equity³ (in %) (footnote: For current year periods and prior year periods, the core return on equity for the respective full year is shown.) | 16.9 | 18.1 |
| Average shareholders' equity⁴ used for core RoE calculation (footnote: Shareholders‘ equity excluding undated subordinated bonds classified as shareholders’ equity, unrealized gains and losses from insurance contracts and other unrealized gains and losses.) | 58,544 | 60,619 |
Allianz Group – EPS
| EUR million | 2024 | 2025 |
|---|---|---|
| Number of shares issued - end of period | 386,166,676 | 380,418,897 |
| Number of shares outstanding - end of period | 385,919,437 | 380,242,198 |
| Weighted average number of shares outstanding - basic | 388,462,381 | 382,873,496 |
| Potentially dilutive shares | 120,869 | 85,195 |
| Weighted average number of shares outstanding - diluted | 388,583,250 | 382,958,691 |
| Net income attributable to shareholders - basic (footnote: Adjusted for net financial charges related to undated subordinated bonds classified as shareholders’ equity. For core EPS basic and core EPS diluted, net financial charges excluding any foreign currency translation effects incurred in the redemption of these bonds.) | 9,788 | 10,603 |
| Effect of dilution | -5 | -5 |
| Net income attributable to shareholders - diluted | 9,783 | 10,598 |
| EPS basic (EUR) | 25.20 | 27.69 |
| EPS diluted (EUR) | 25.18 | 27.67 |
| Shareholders' core net income - basic | 9,874 | 10,953 |
| Effect of dilution | -5 | -5 |
| Shareholders' core net income - diluted | 9,869 | 10,948 |
| Core EPS basic (EUR) | 25.42 | 28.61 |
| Core EPS diluted (EUR) | 25.40 | 28.59 |
Property-Casualty
| EUR million | 2024 | 2025 |
|---|---|---|
| Total business volume (footnote: Total business volume comprises gross premiums written and fee and commission income.) | 82,883 | 86,741 |
| Operating insurance service result | — | — |
| Operating insurance revenue | 74,619 | 78,164 |
| Claims and benefits | -48,771 | -50,386 |
| Operating acquisition and administrative expenses | -18,022 | -18,645 |
| Operating reinsurance result | -2,927 | -3,000 |
| Other insurance service result | 10 | 0 |
| Subtotal | 4,908 | 6,133 |
| Operating investment result | — | — |
| Interest and similar income (footnote: Net of interest expenses.) | 4,980 | 4,737 |
| Interest accretion | -1,159 | -1,336 |
| Valuation result & other (footnote: Other comprises realized gains/losses, investment expenses, F/X gains/losses on insurance assets/liabilities and other.) | -811 | -549 |
| Thereof: investment expenses | -539 | -418 |
| Subtotal | 3,011 | 2,851 |
| Operating fee and commission result | 59 | 70 |
| Operating other result | -79 | -61 |
| Operating profit | 7,898 | 8,992 |
| Non-operating items | — | — |
| Realized gains/losses (net) | -68 | 327 |
| Expected credit loss and impairments (net) | -29 | -12 |
| Result from assets and liabilities measured at fair value incl. derivatives | 32 | -269 |
| Thereof: non-operating market movements | 47 | -265 |
| Restructuring and integration expenses | -387 | -476 |
| Amortization of intangible assets | -196 | -193 |
| Thereof: amortization of intangible assets from business combinations | -77 | -71 |
| Other (footnote: Including hyperinflation result.) | -318 | -226 |
| Subtotal | -966 | -849 |
| Income (loss) before income taxes | 6,932 | 8,144 |
| Income taxes | -1,691 | -2,225 |
| Net income (loss) | 5,241 | 5,918 |
| Net income (loss) attributable to: | — | — |
| Non-controlling interests | 144 | 215 |
| Shareholders | 5,097 | 5,703 |
| Income (loss) before income taxes | 6,932 | 8,144 |
| Adjustment for non-operating market movements | -47 | 265 |
| Adjustment for amortization of intangible assets from business combinations | 77 | 71 |
| Core income (loss) before income taxes | 6,962 | 8,479 |
| Income taxes related to core income | -1,688 | -2,264 |
| Core net income (loss) | 5,274 | 6,215 |
| thereof: Shareholders' core net income (loss) | 5,119 | 5,991 |
| Loss ratio⁵ (in %) (footnote: Reinsurance ratio: 3.8% in 4Q 25 (4Q 24: 1.9%), 3.8% in 12M 25 (12M 24: 3.9%).) | 69.3 | 68.3 |
| Attritional loss ratio (in %) | 69.0 | 68.8 |
| thereof: discounting impact (in %) | -2.8 | -2.5 |
| NatCat impact (in %) | 2.4 | 1.4 |
| Run-off ratio (in %) | -2.1 | -1.9 |
| Expense ratio (in %) | 24.2 | 23.9 |
| Combined ratio (in %) | 93.4 | 92.2 |
| Core return on equity⁶ (in %) (footnote: For current year periods and prior year periods, the core return on equity for the respective full year is shown.) | 13.5 | 15.1 |
| Risk adjustment (net of reinsurance) (footnote: Refers to liability of incurred claims (LIC), not directly related to the loss ratio.) | 1,499 | 1,442 |
P&C by Region YTD
| EUR mn | % | EUR mn | % | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EUR million | Total business volume (footnote: Total business volume comprises gross premiums written and fee and commission income.) | Total business volume | Operating insurance revenue | Operating profit (loss) | Combined ratio | Loss ratio | Expense ratio | ||||||
| 12M | |||||||||||||
| — | — | — | Internal growth (footnote: This reflects the growth of total business volume on an internal basis, adjusted for foreign currency translation and (de-)consolidation effects.) | — | — | — | — | — | — | — | — | — | — |
| Germany | 13,399 | 14,134 | 9.8 | 12,596 | 13,598 | 1,376 | 1,899 | 93.0 | 88.9 | 68.6 | 65.0 | 24.5 | 24.0 |
| Switzerland | 2,214 | 2,342 | 3.8 | 2,182 | 2,297 | 293 | 289 | 90.0 | 89.8 | 67.3 | 66.9 | 22.7 | 22.9 |
| Central Europe | 4,570 | 4,623 | 4.5 | 4,414 | 4,505 | 565 | 583 | 89.6 | 89.5 | 63.3 | 62.5 | 26.3 | 27.0 |
| German speaking countries and central Europe | 20,182 | 21,099 | 7.9 | 19,192 | 20,399 | 2,234 | 2,771 | 91.9 | 89.2 | 67.2 | 64.6 | 24.7 | 24.5 |
| Italy | 5,481 | 5,682 | 3.7 | 5,285 | 5,449 | 652 | 705 | 90.8 | 90.8 | 63.5 | 63.8 | 27.3 | 27.0 |
| France | 5,107 | 5,456 | 6.8 | 5,019 | 5,342 | 527 | 517 | 93.6 | 94.0 | 70.2 | 70.7 | 23.4 | 23.3 |
| Benelux | 1,486 | 1,540 | 3.6 | 1,483 | 1,544 | 150 | 156 | 93.6 | 94.3 | 66.5 | 67.3 | 27.1 | 27.0 |
| Türkiye | 2,224 | 2,264 | 40.2 | 1,714 | 1,905 | 385 | 477 | 103.0 | 99.4 | 83.5 | 79.9 | 19.5 | 19.5 |
| Greece | 299 | 283 | -5.4 | 272 | 286 | 24 | 19 | 94.7 | 96.4 | 63.0 | 64.1 | 31.7 | 32.3 |
| Allianz partners | 10,076 | 10,587 | 7.2 | 7,138 | 7,638 | 333 | 402 | 97.1 | 96.7 | 69.9 | 69.7 | 27.1 | 26.9 |
| Allianz direct | 1,253 | 1,542 | 19.8 | 1,079 | 1,482 | 50 | 75 | 97.4 | 95.5 | 81.6 | 80.7 | 15.7 | 14.8 |
| Western & southern Europe, Allianz direct and Allianz partners | 25,926 | 27,354 | 9.4 | 21,991 | 23,645 | 2,122 | 2,350 | 95.0 | 94.7 | 69.7 | 69.9 | 25.2 | 24.8 |
| Australia | 5,040 | 5,179 | 6.1 | 4,679 | 4,850 | 514 | 350 | 91.2 | 95.4 | 68.7 | 73.6 | 22.5 | 21.8 |
| Asia Pacific other | 2,013 | 2,166 | 9.7 | 1,969 | 2,123 | 175 | 170 | 97.7 | 96.5 | 67.1 | 66.4 | 30.6 | 30.1 |
| Asia Pacific | 7,053 | 7,345 | 7.1 | 6,648 | 6,974 | 689 | 520 | 93.1 | 95.7 | 68.3 | 71.4 | 24.9 | 24.3 |
| AGCS | 12,141 | 12,053 | 3.5 | 11,222 | 10,667 | 825 | 780 | 95.6 | 95.5 | 76.4 | 76.4 | 19.2 | 19.1 |
| Thereof: AGCS excluding fronting & captives (footnote: Internal growth exlcudes Arch transaction.) | 7,880 | 7,788 | 7.8 | 7,026 | 6,588 | 825 | 780 | 92.9 | 92.7 | 70.9 | 68.9 | 22.0 | 23.8 |
| Reinsurance P/C and other | 5,739 | 6,426 | 14.9 | 3,620 | 4,006 | 191 | 539 | 97.3 | 88.1 | 94.0 | 84.6 | 3.3 | 3.5 |
| Allianz trade | 3,966 | 4,004 | 2.1 | 3,242 | 3,216 | 668 | 700 | 82.9 | 81.7 | 55.8 | 54.7 | 27.1 | 27.0 |
| United Kingdom | 5,506 | 5,421 | -0.3 | 5,235 | 5,264 | 434 | 556 | 95.0 | 93.0 | 71.7 | 70.0 | 23.2 | 22.9 |
| Ireland | 801 | 877 | 9.5 | 747 | 838 | 127 | 127 | 86.4 | 87.5 | 62.5 | 64.1 | 23.8 | 23.3 |
| Spain | 3,114 | 3,371 | 8.3 | 2,969 | 3,247 | 163 | 168 | 96.5 | 96.4 | 74.1 | 74.2 | 22.4 | 22.2 |
| Portugal | 607 | 699 | 15.2 | 585 | 672 | 60 | 68 | 90.5 | 90.8 | 68.4 | 69.0 | 22.2 | 21.9 |
| Latin America | 2,984 | 3,187 | 18.1 | 2,839 | 2,969 | 328 | 321 | 96.1 | 93.9 | 70.5 | 68.4 | 25.6 | 25.4 |
| Africa | n.m. | n.m. | n.m. | n.m. | n.m. | 45 | 93 | n.m. | n.m. | n.m. | n.m. | n.m. | n.m. |
| Middle East | 36 | n.m. | n.m. | 56 | n.m. | n.m. | n.m. | 101.9 | n.m. | 81.8 | n.m. | 20.2 | n.m. |
| Global insurance lines & Anglo markets, Iberia & Latin America, Africa | 34,894 | 36,039 | 6.7 | 30,516 | 30,879 | 2,841 | 3,351 | 94.2 | 92.3 | 74.2 | 72.6 | 19.9 | 19.7 |
| Consolidation (footnote: Represents elimination of transactions between Allianz Group entities in different geographic regions.) | -5,173 | -5,096 | n.m. | -3,728 | -3,734 | 12 | n.m. | n.m. | n.m. | n.m. | n.m. | n.m. | n.m. |
| Total | 82,883 | 86,741 | 8.2 | 74,619 | 78,164 | 7,898 | 8,992 | 93.4 | 92.2 | 69.3 | 68.3 | 24.2 | 23.9 |
P&C by Region QTD
| EUR mn | % | EUR mn | % | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EUR million | Total business volume (footnote: Total business volume comprises gross premiums written and fee and commission income.) | Total business volume | Operating insurance revenue | Operating profit (loss) | Combined ratio | Loss ratio | Expense ratio | ||||||
| 4Q 24 | 4Q 25 | 4Q 24 | 4Q 25 | 4Q 24 | 4Q 25 | 4Q 24 | 4Q 25 | 4Q 24 | 4Q 25 | 4Q 24 | 4Q 25 | ||
| — | — | — | Internal growth (footnote: This reflects the growth of total business volume on an internal basis, adjusted for foreign currency translation and (de-)consolidation effects.) | — | — | — | — | — | — | — | — | — | — |
| Germany | 2,614 | 2,759 | 11.8 | 3,215 | 3,469 | 442 | 365 | 90.4 | 93.3 | 65.3 | 67.7 | 25.1 | 25.6 |
| Switzerland | 251 | 300 | 11.8 | 547 | 586 | 56 | 96 | 93.2 | 85.1 | 70.0 | 61.0 | 23.1 | 24.1 |
| Central Europe | 1,083 | 1,108 | 5.2 | 1,123 | 1,148 | 174 | 172 | 87.3 | 88.8 | 60.4 | 61.9 | 26.9 | 26.9 |
| German speaking countries and central Europe | 3,948 | 4,168 | 10.0 | 4,885 | 5,203 | 672 | 632 | 90.0 | 91.4 | 64.7 | 65.7 | 25.3 | 25.7 |
| Italy | 1,658 | 1,735 | 4.7 | 1,376 | 1,413 | 162 | 198 | 92.4 | 90.4 | 64.5 | 64.1 | 27.9 | 26.3 |
| France | 1,147 | 1,214 | 5.8 | 1,298 | 1,376 | 96 | 141 | 98.8 | 94.4 | 75.5 | 71.1 | 23.3 | 23.3 |
| Benelux | 287 | 295 | 2.9 | 378 | 391 | 29 | 58 | 93.3 | 89.8 | 65.1 | 61.4 | 28.2 | 28.4 |
| Türkiye | 788 | 672 | 17.5 | 552 | 485 | 114 | 114 | 107.1 | 101.6 | 88.1 | 82.1 | 19.0 | 19.5 |
| Greece | 86 | 74 | -14.3 | 70 | 73 | 7 | 8 | 94.6 | 91.1 | 64.2 | 59.1 | 30.4 | 32.0 |
| Allianz partners | 2,321 | 2,291 | 3.5 | 1,882 | 1,880 | 70 | 102 | 99.2 | 97.2 | 73.2 | 70.2 | 26.0 | 27.1 |
| Allianz direct | 312 | 377 | 16.1 | 276 | 389 | 30 | 20 | 93.5 | 95.8 | 77.3 | 85.3 | 16.2 | 10.5 |
| Western & southern Europe, Allianz direct and Allianz partners | 6,600 | 6,658 | 6.2 | 5,834 | 6,007 | 508 | 641 | 97.5 | 94.7 | 72.6 | 70.2 | 24.9 | 24.5 |
| Australia | 1,263 | 1,314 | 4.0 | 1,241 | 1,310 | 108 | -100 | 93.5 | 112.2 | 70.4 | 91.1 | 23.1 | 21.1 |
| Asia Pacific other | 522 | 519 | 6.5 | 567 | 557 | 46 | 38 | 98.9 | 97.3 | 64.6 | 65.5 | 34.3 | 31.8 |
| Asia Pacific | 1,786 | 1,832 | 4.7 | 1,807 | 1,867 | 155 | -62 | 95.2 | 107.7 | 68.6 | 83.4 | 26.6 | 24.3 |
| AGCS | 2,912 | 2,786 | 4.4 | 3,078 | 2,812 | 148 | 189 | 98.0 | 96.2 | 80.5 | 77.7 | 17.5 | 18.5 |
| Thereof: AGCS excluding fronting & captives (footnote: Internal growth exlcudes Arch transaction.) | 1,765 | 1,947 | 9.4 | 1,611 | 1,747 | 148 | 189 | 96.3 | 93.9 | 75.0 | 69.3 | 21.2 | 24.6 |
| Reinsurance P/C and other | 1,147 | 1,114 | 4.1 | 1,012 | 1,024 | 55 | 181 | 97.9 | 84.8 | 94.7 | 81.0 | 3.2 | 3.8 |
| Allianz trade | 910 | 879 | -1.2 | 815 | 793 | 146 | 184 | 85.3 | 80.5 | 58.4 | 53.2 | 26.9 | 27.3 |
| United Kingdom | 1,331 | 1,289 | 1.8 | 1,358 | 1,290 | 95 | 123 | 97.4 | 94.7 | 72.3 | 70.2 | 25.2 | 24.5 |
| Ireland | 188 | 202 | 7.9 | 199 | 217 | 25 | 33 | 91.4 | 88.3 | 67.1 | 64.5 | 24.2 | 23.8 |
| Spain | 789 | 855 | 8.3 | 772 | 842 | 1 | 52 | 101.8 | 95.6 | 78.7 | 74.7 | 23.1 | 20.9 |
| Portugal | 125 | 144 | 14.7 | 152 | 176 | 15 | 19 | 91.1 | 90.8 | 68.6 | 69.1 | 22.5 | 21.7 |
| Latin America | 805 | 894 | 14.3 | 718 | 802 | 60 | 90 | 99.1 | 94.6 | 72.2 | 69.8 | 26.9 | 24.8 |
| Africa | n.m. | n.m. | n.m. | n.m. | n.m. | 13 | 4 | n.m. | n.m. | n.m. | n.m. | n.m. | n.m. |
| Middle East | n.m. | n.m. | n.m. | n.m. | n.m. | 0 | n.m. | n.m. | n.m. | n.m. | n.m. | n.m. | n.m. |
| Global insurance lines & Anglo markets, Iberia & Latin America, Africa | 8,208 | 8,164 | 4.9 | 8,105 | 7,957 | 558 | 874 | 96.8 | 92.4 | 77.2 | 72.8 | 19.6 | 19.6 |
| Consolidation (footnote: Represents elimination of transactions between Allianz Group entities in different geographic regions.) | -1,007 | -949 | n.m. | -1,035 | -953 | 56 | 49 | n.m. | n.m. | n.m. | n.m. | n.m. | n.m. |
| Total | 19,534 | 19,873 | 6.7 | 19,596 | 20,081 | 1,948 | 2,134 | 94.7 | 93.6 | 70.7 | 69.8 | 24.1 | 23.8 |
P&C by Customer Segment YTD
| EUR million | Property-Casualty | Retail lines (footnote: Retail including SME and Fleet.) | Retail lines | Commercial lines (footnote: Commercial including large corporate, MidCorp, credit insurance, internal and 3rd party reinsurance.) | Commercial lines | Not allocated | ||
|---|---|---|---|---|---|---|---|---|
| — | 12M | |||||||
| Total business volume (footnote: Total business volume comprises gross premiums written and fee and commission income.) | 82,883 | 86,741 | 50,229 | 52,789 | 32,711 | 33,828 | -58 | 124 |
| Operating insurance revenue | 74,619 | 78,164 | 46,219 | 49,505 | 28,209 | 28,579 | 191 | 80 |
| In % | — | — | — | — | — | — | — | — |
| Combined ratio | 93.4 | 92.2 | 94.1 | 92.4 | 92.2 | 91.7 | — | — |
| Loss ratio | 69.3 | 68.3 | 67.9 | 66.6 | 71.5 | 71.1 | — | — |
| Expense ratio | 24.2 | 23.9 | 26.3 | 25.8 | 20.7 | 20.5 | — | — |
P&C by Customer Segment QTD
Life & Health
| EUR million | 2024 | 2025 |
|---|---|---|
| Total business volume (footnote: Total business volume comprises statutory gross premiums.) | 89,317 | 92,314 |
| Release CSM | 5,137 | 5,440 |
| Release risk adjustment | 488 | 523 |
| Variances from claims and expenses (footnote: Including operating reinsurance result.) | 56 | 46 |
| Losses on onerous contracts | -41 | -84 |
| Non-attributable expenses | -1,141 | -1,202 |
| Operating investment result | 662 | 525 |
| Other operating result | 343 | 353 |
| Operating profit | 5,505 | 5,601 |
| Non-operating items | — | — |
| Realized gains/losses (net) | -120 | 223 |
| Expected credit loss and impairments (net) | 11 | -8 |
| Result from assets and liabilities measured at fair value incl. derivatives | -47 | -33 |
| Thereof: non-operating market movements | 0 | 15 |
| Restructuring and integration expenses | -55 | -71 |
| Amortization of intangible assets | -68 | -56 |
| Thereof: amortization of intangible assets from business combinations | -11 | -10 |
| Other (including tax reclassifications) (footnote: Including hyperinflation result.) | 163 | 59 |
| Subtotal | -117 | 114 |
| Income (loss) before income taxes | 5,388 | 5,715 |
| Income taxes | -1,300 | -1,579 |
| Net income (loss) | 4,088 | 4,137 |
| Net income (loss) attributable to: | — | — |
| Non-controlling interests | 176 | 203 |
| Shareholders | 3,912 | 3,934 |
| Income (loss) before income taxes | 5,388 | 5,715 |
| Adjustment for non-operating market movements | -0 | -15 |
| Adjustment for amortization of intangible assets from business combinations | 11 | 10 |
| Core income (loss) before income taxes | 5,400 | 5,711 |
| Income taxes related to core income | -1,303 | -1,576 |
| Core net income (loss) | 4,097 | 4,135 |
| thereof: Shareholders' core net income (loss) | 3,917 | 3,928 |
| Core return on equity⁴ (in %) (footnote: For current year periods and prior year periods, the core return on equity for the respective full year is shown.) | 16.3 | 15.2 |
| Operating asset base (in EUR bn) | 783.5 | 769.8 |
| Net flows (in EUR bn) | 4.7 | 11.7 |
| Risk adjustment (gross of reinsurance) (footnote: Refers to liability for remaining coverage (LRC).) | 4,928 | 4,836 |
L&H New Business YTD
| EUR million | Present value of new business premiums | New business margin | Value of new business | |||
|---|---|---|---|---|---|---|
| EUR mn | % | EUR mn | ||||
| — | 12M | |||||
| Germany life | 18,614 | 18,292 | 4.7 | 4.6 | 884 | 833 |
| Germany health | 3,609 | 5,382 | 5.7 | 5.6 | 206 | 300 |
| Germany APR | n.m. | 359 | n.m. | 7.9 | n.m. | 28 |
| Switzerland | 840 | 1,047 | 4.8 | 4.6 | 40 | 48 |
| Central Europe (footnote: Includes the Austrian health business from 01.01.2025.) | 1,633 | 2,074 | 9.9 | 10.6 | 162 | 220 |
| German speaking countries and Central Europe | 24,697 | 27,153 | 5.2 | 5.3 | 1,292 | 1,429 |
| Italy | 14,099 | 14,325 | 3.6 | 3.5 | 513 | 505 |
| France | 6,665 | 6,871 | 4.6 | 5.3 | 305 | 365 |
| Benelux | 2,164 | 2,569 | 4.2 | 4.5 | 90 | 116 |
| Türkiye | 1,696 | 2,474 | 7.0 | 6.1 | 118 | 151 |
| Greece | 86 | 96 | 2.5 | 2.5 | 2 | 2 |
| Western & Southern Europe | 24,709 | 26,335 | 4.2 | 4.3 | 1,029 | 1,140 |
| Asia Pacific | 7,185 | 7,757 | 9.8 | 9.2 | 707 | 716 |
| USA | 21,843 | 21,239 | 6.1 | 6.3 | 1,337 | 1,345 |
| Reinsurance L/H | 1,687 | 210 | 8.1 | 8.3 | 137 | 17 |
| Spain | 574 | 627 | 3.6 | 3.4 | 20 | 22 |
| Portugal | 192 | 222 | 14.8 | 11.1 | 28 | 25 |
| Latin America | 1,063 | 1,730 | 13.4 | 7.8 | 143 | 136 |
| Global insurance lines & Anglo markets, Iberia & Latin America, Africa | 3,516 | 2,788 | 9.4 | 7.2 | 329 | 199 |
| Consolidation and other | -123 | -591 | n.m. | n.m. | n.m. | n.m. |
| Total | 81,827 | 84,682 | 5.7 | 5.7 | 4,694 | 4,829 |
| EUR million | 12M | |
|---|---|---|
| Value of new business | 4,694 | 4,829 |
| Non-attributable expenses | 693 | 772 |
| Scope / other | 681 | -183 |
| CSM at inception | 6,067 | 5,419 |
L&H New Business QTD
| EUR million | Present value of new business premiums | New business margin | Value of new business | |||
|---|---|---|---|---|---|---|
| EUR mn | % | EUR mn | ||||
| — | 4Q 24 | 4Q 25 | 4Q 24 | 4Q 25 | 4Q 24 | 4Q 25 |
| Germany life | 5,786 | 4,634 | 4.5 | 4.6 | 259 | 212 |
| Germany health | 1,044 | 1,306 | 5.9 | 5.8 | 62 | 76 |
| Germany APR | n.m. | 113 | n.m. | 7.8 | n.m. | 9 |
| Switzerland | 161 | 172 | 5.2 | 5.2 | 8 | 9 |
| Central Europe (footnote: Includes the Austrian health business from 01.01.2025.) | 456 | 605 | 9.2 | 10.4 | 42 | 63 |
| German speaking countries and Central Europe | 7,447 | 6,830 | 5.0 | 5.4 | 371 | 368 |
| Italy | 3,997 | 3,261 | 3.7 | 4.2 | 149 | 136 |
| France | 1,039 | 1,272 | 4.8 | 4.9 | 50 | 62 |
| Benelux | 555 | 677 | 4.4 | 4.0 | 24 | 27 |
| Türkiye | 517 | 818 | 6.7 | 5.1 | 35 | 42 |
| Greece | 27 | 29 | 2.8 | 3.4 | 1 | 1 |
| Western & Southern Europe | 6,136 | 6,057 | 4.2 | 4.4 | 258 | 268 |
| Asia Pacific | 1,836 | 1,787 | 10.2 | 9.6 | 187 | 172 |
| USA | 5,224 | 5,731 | 5.6 | 6.2 | 292 | 355 |
| Reinsurance L/H | 47 | 108 | 9.5 | 5.3 | 4 | 6 |
| Spain | 175 | 202 | 3.9 | 2.7 | 7 | 5 |
| Portugal | 80 | 84 | 8.8 | 8.4 | 7 | 7 |
| Latin America | 296 | 473 | 10.0 | 7.6 | 30 | 36 |
| Global insurance lines & Anglo markets, Iberia & Latin America, Africa | 598 | 866 | 8.0 | 6.2 | 48 | 54 |
| Consolidation and other | -33 | -107 | n.m. | n.m. | n.m. | n.m. |
| Total | 21,207 | 21,163 | 5.5 | 5.8 | 1,156 | 1,217 |
| EUR million | 4Q 24 | 4Q 25 |
|---|---|---|
| Value of new business | 1,156 | 1,217 |
| Non-attributable expenses | 184 | 195 |
| Scope / other | 801 | -59 |
| CSM at inception | 2,142 | 1,353 |
L&H by Region YTD
| EUR mn | % | EUR mn | |||||||
|---|---|---|---|---|---|---|---|---|---|
| EUR million | Total business volume (footnote: Total business volume comprises statutory gross premiums.) | Total business volume | Operating insurance revenue | Operating profit (loss) | Contractual service margin (footnote: Includes gross CSM of EUR 0.8bn as of 31.12.2024, for UniCredit Allianz Vita S.p.A., which was classified as held for sale in the 3Q 24. Sale has been completed in 2Q 25.) | Contractual service margin | |||
| 12M | 31.12.2024 | 31.12.2025 | |||||||
| — | — | — | Internal growth (footnote: This reflects the growth of total business volume on an internal basis, adjusted for foreign currency translation and (de-)consolidation effects.) | — | — | — | — | — | — |
| Germany life | 24,421 | 26,929 | 10.3 | 5,349 | 5,810 | 1,184 | 1,192 | 15,840 | 16,916 |
| Germany health | 4,322 | 4,663 | 7.9 | 4,386 | 4,720 | 244 | 259 | 7,379 | 7,437 |
| Germany APR | n.m. | 474 | 1.2 | n.m. | 165 | n.m. | 67 | n.m. | 515 |
| Switzerland | 1,697 | 1,767 | 3.0 | 491 | 483 | 120 | 122 | 1,838 | 1,830 |
| Central Europe (footnote: Includes the Austrian health business from 01.01.2025.) | 2,118 | 2,402 | 5.0 | 1,044 | 1,309 | 517 | 588 | 2,002 | 2,951 |
| German speaking countries and Central Europe | 32,559 | 36,236 | 9.1 | 11,271 | 12,486 | 2,065 | 2,229 | 27,059 | 29,649 |
| Italy | 13,257 | 12,485 | 15.5 | 1,421 | 1,141 | 585 | 494 | 3,532 | 2,978 |
| France | 8,003 | 7,911 | -1.1 | 3,888 | 3,811 | 625 | 645 | 4,306 | 4,655 |
| Benelux | 2,424 | 2,571 | 6.1 | 441 | 472 | 151 | 152 | 981 | 1,126 |
| Türkiye | 1,474 | 2,057 | 92.2 | 165 | 192 | 180 | 189 | 105 | 129 |
| Greece | 157 | 163 | 3.8 | 114 | 116 | 3 | -6 | 54 | 54 |
| Western & Southern Europe | 25,315 | 25,187 | 13.5 | 6,029 | 5,731 | 1,544 | 1,474 | 8,977 | 8,942 |
| Asia Pacific | 6,795 | 7,304 | 9.6 | 2,311 | 2,524 | 620 | 603 | 5,306 | 5,296 |
| USA | 22,383 | 21,829 | 2.0 | 2,666 | 2,812 | 1,076 | 1,038 | 13,169 | 10,923 |
| Reinsurance L/H | 578 | 542 | -6.6 | 505 | 484 | 39 | 47 | 663 | 520 |
| Spain | 618 | 268 | 4.6 | 294 | 414 | 65 | 76 | 417 | 364 |
| Portugal | 182 | 168 | -7.5 | 77 | 74 | 15 | 13 | 1 | 1 |
| Latin America | 1,017 | 1,286 | 37.9 | 127 | 129 | 93 | 99 | 112 | 118 |
| Africa | n.m. | n.m. | n.m. | n.m. | n.m. | 24 | 63 | n.m. | n.m. |
| Middle East | 5 | n.m. | n.m. | 3 | n.m. | n.m. | n.m. | n.m. | n.m. |
| Global insurance lines & Anglo markets, Iberia & Latin America, Africa | 2,400 | 2,264 | 15.1 | 1,007 | 1,101 | 236 | 296 | 1,192 | 1,002 |
| Consolidation and other (footnote: Includes small entities and elimination of transactions between Allianz Group entities in different geographic regions.) | -135 | -507 | n.m. | -145 | -128 | -35 | -39 | -132 | -108 |
| Total | 89,317 | 92,314 | 8.2 | 23,138 | 24,527 | 5,505 | 5,601 | 55,571 | 55,703 |
L&H by Region QTD
| EUR mn | % | EUR mn | |||||||
|---|---|---|---|---|---|---|---|---|---|
| EUR million | Total business volume (footnote: Total business volume comprises statutory gross premiums.) | Total business volume | Operating insurance revenue | Operating profit (loss) | Contractual service margin (footnote: Includes gross CSM of EUR 0.8bn as of 31.12.2024, for UniCredit Allianz Vita S.p.A., which was classified as held for sale in the 3Q 24. Sale has been completed in 2Q 25.) | Contractual service margin | |||
| 4Q 24 | 4Q 25 | 4Q 24 | 4Q 25 | 4Q 24 | 4Q 25 | 31.12.2024 | 31.12.2025 | ||
| — | — | — | Internal growth (footnote: This reflects the growth of total business volume on an internal basis, adjusted for foreign currency translation and (de-)consolidation effects.) | — | — | — | — | — | — |
| Germany life | 7,358 | 6,124 | -16.8 | 1,601 | 1,866 | 328 | 332 | 15,840 | 16,916 |
| Germany health | 1,087 | 1,177 | 8.2 | 1,137 | 1,186 | 81 | 76 | 7,379 | 7,437 |
| Germany APR | n.m. | 130 | 4.6 | n.m. | 39 | n.m. | 14 | n.m. | 515 |
| Switzerland | 261 | 278 | 5.6 | 129 | 124 | 33 | 38 | 1,838 | 1,830 |
| Central Europe (footnote: Includes the Austrian health business from 01.01.2025.) | 551 | 645 | 7.9 | 276 | 354 | 128 | 145 | 2,002 | 2,951 |
| German speaking countries and Central Europe | 9,257 | 8,355 | -11.4 | 3,144 | 3,570 | 570 | 605 | 27,059 | 29,649 |
| Italy | 3,809 | 3,017 | 18.9 | 469 | 270 | 132 | 91 | 3,532 | 2,978 |
| France | 2,101 | 2,288 | 8.9 | 904 | 866 | 151 | 193 | 4,306 | 4,655 |
| Benelux | 696 | 790 | 13.5 | 121 | 123 | 37 | 42 | 981 | 1,126 |
| Türkiye | 511 | 742 | 99.9 | 52 | 49 | 56 | 46 | 105 | 129 |
| Greece | 43 | 45 | 3.6 | 30 | 31 | -0 | -4 | 54 | 54 |
| Western & Southern Europe | 7,161 | 6,882 | 21.6 | 1,576 | 1,339 | 376 | 368 | 8,977 | 8,942 |
| Asia Pacific | 1,794 | 1,763 | 4.9 | 614 | 651 | 164 | 104 | 5,306 | 5,296 |
| USA | 5,417 | 5,882 | 18.4 | 717 | 707 | 250 | 209 | 13,169 | 10,923 |
| Reinsurance L/H | 143 | 126 | -12.8 | 110 | 127 | 14 | 13 | 663 | 520 |
| Spain | 191 | 207 | 8.4 | 76 | 73 | 19 | 20 | 417 | 364 |
| Portugal | 76 | 76 | -0.1 | 19 | 18 | 3 | 2 | 1 | 1 |
| Latin America | 261 | 377 | 43.0 | 33 | 37 | 23 | 26 | 112 | 118 |
| Africa | n.m. | n.m. | n.m. | n.m. | n.m. | 4 | 21 | n.m. | n.m. |
| Middle East | n.m. | n.m. | n.m. | n.m. | n.m. | n.m. | n.m. | n.m. | n.m. |
| Global insurance lines & Anglo markets, Iberia & Latin America, Africa | 671 | 785 | 16.4 | 239 | 255 | 63 | 83 | 1,192 | 1,002 |
| Consolidation and other (footnote: Includes small entities and elimination of transactions between Allianz Group entities in different geographic regions.) | -25 | -25 | n.m. | -25 | -45 | -0 | -5 | -132 | -108 |
| Total | 24,277 | 23,642 | 6.0 | 6,264 | 6,476 | 1,424 | 1,364 | 55,571 | 55,703 |
L&H Details YTD
| EUR million | Life/health segment | Capital-efficient products | Unit-linked without guarantees | Protection & health | Guaranteed savings & annuities | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| — | 12M | 12M 25 (footnote: Includes the German APR and the Austrian health businesses from 01.01.2025.) | 12M | |||||||
| Release CSM | 5,137 | 5,440 | 1,602 | 1,625 | 619 | 637 | 1,537 | 1,702 | 1,378 | 1,476 |
| Release risk adjustment | 488 | 523 | 104 | 105 | 70 | 81 | 212 | 228 | 102 | 108 |
| Variances from claims and expenses (footnote: Including operating reinsurance result.) | 56 | 46 | 49 | 188 | -15 | -21 | -18 | -26 | 40 | -96 |
| Losses on onerous contracts | -41 | -84 | -1 | -2 | 1 | -2 | -37 | -60 | -4 | -20 |
| Non-attributable expenses | -1,141 | -1,202 | -289 | -295 | -96 | -80 | -350 | -367 | -405 | -460 |
| Operating investment result | 662 | 525 | 80 | -52 | 80 | 92 | 45 | 19 | 456 | 467 |
| Other operating result | 343 | 353 | 22 | 34 | 292 | 285 | -7 | 2 | 36 | 32 |
| Operating profit | 5,505 | 5,601 | 1,567 | 1,603 | 952 | 993 | 1,382 | 1,498 | 1,604 | 1,507 |
| Total business volume (footnote: Total business volume comprises statutory gross premiums.) | 89,317 | 92,314 | 40,884 | 41,759 | 19,922 | 21,405 | 15,319 | 15,908 | 13,191 | 13,242 |
| Operating insurance revenue | 23,138 | 24,527 | 3,433 | 3,733 | 1,577 | 1,592 | 12,820 | 13,558 | 5,307 | 5,644 |
| Contractual service margin (gross) (footnote: Includes gross CSM of EUR 0.8bn as of 31.12.2024, for UniCredit Allianz Vita S.p.A., which was classified as held for sale in the 3Q 24. Sale has been completed in 2Q 25.) | 55,571 | 55,703 | 17,190 | 16,245 | 6,045 | 6,382 | 17,388 | 18,018 | 14,948 | 15,058 |
| PVFCF (footnote: Refers to liability for remaining coverage (LRC). Includes gross PVFCF of 21.2bn as of 31.12.2024, for UniCredit Allianz Vita S.p.A., which was classified as held for sale in the 3Q 24. Sale has been completed in 2Q 25.) | 649,968 | 633,941 | 234,052 | 237,659 | 83,794 | 78,990 | 46,648 | 45,147 | 285,474 | 272,145 |
| Present value of new business premiums | 81,827 | 84,682 | 40,403 | 37,961 | 19,478 | 22,380 | 16,072 | 16,960 | 5,874 | 7,381 |
| New business margin (in %) | 5.7 | 5.7 | 5.2 | 5.3 | 4.2 | 4.1 | 9.2 | 9.2 | 5.1 | 4.9 |
| Value of new business | 4,694 | 4,829 | 2,112 | 2,002 | 813 | 907 | 1,472 | 1,562 | 297 | 358 |
L&H Details QTD
Asset Management
| EUR million | 2024 | 2025 |
|---|---|---|
| Net operating revenues | — | — |
| Net fee and commission income | 8,186 | 8,408 |
| Thereof: net fee and commission income excl. performance fees (footnote: Excluding performance fees and other income.) | 7,640 | 8,007 |
| Thereof: performance fees | 545 | 402 |
| Other operating revenues | 139 | 99 |
| Subtotal | 8,324 | 8,507 |
| Operating expenses | -5,086 | -5,162 |
| Operating profit (footnote: Includes operating result from PIMCO, AllianzGI and other entities.) | 3,239 | 3,345 |
| Thereof: PIMCO | 2,518 | 2,593 |
| Thereof: AllianzGI | 733 | 770 |
| Non-operating items | — | — |
| Realized gains/losses (net) | 17 | 94 |
| Expected credit loss and impairments (net) | -0 | -0 |
| Result from assets and liabilities measured at fair value incl. derivatives | 11 | 9 |
| Thereof: non-operating market movements | 11 | 9 |
| Restructuring and integration expenses | -11 | -64 |
| Amortization of intangible assets | -7 | -7 |
| Thereof: amortization of intangible assets from business combinations | -2 | -2 |
| Other (footnote: Includes mainly reclassification effects from operating to non-operating result related to a disposal of an investment as of 30.06.2025 and, if applicable, acquisition-related expenses, income taxes related incidental benefits/expenses and litigation expenses.) | 8 | -29 |
| Subtotal | 18 | 3 |
| Income (loss) before income taxes | 3,257 | 3,348 |
| Income taxes | -829 | -835 |
| Net income (loss) | 2,428 | 2,513 |
| Net income (loss) attributable to: | — | — |
| Non-controlling interests | 210 | 226 |
| Shareholders | 2,218 | 2,287 |
| Income (loss) before income taxes | 3,257 | 3,348 |
| Adjustment for non-operating market movements | -11 | -9 |
| Adjustment for amortization of intangible assets from business combinations | 2 | 2 |
| Core income (loss) before income taxes | 3,248 | 3,341 |
| Income taxes related to core income (loss) | -826 | -834 |
| Core net income (loss) | 2,421 | 2,507 |
| thereof: Shareholders' core net income (loss) | 2,211 | 2,282 |
| Cost-income ratio (in %) | 61.1 | 60.7 |
| Thereof: PIMCO | 59.6 | 59.8 |
| Thereof: AllianzGI | 64.9 | 62.4 |
| 3rd party AuM margin³ (in bps) | 38.5 | 38.2 |
| Thereof: PIMCO | 37.6 | 37.4 |
| Thereof: AllianzGI | 42.0 | 41.2 |
| Core return on equity⁴ (in %) (footnote: For current year periods and prior year periods, the core return on equity for the respective full year is shown.) | 21.5 | 22.3 |
AM AUM
| EUR billion | 2024 | 2025 |
|---|---|---|
| Assets under management | 2,448 | 2,512 |
| Allianz Group assets under management | 528 | 522 |
| Third-party assets under management | 1,920 | 1,990 |
| Thereof: PIMCO | 1,521 | 1,573 |
| Thereof: AllianzGI | 399 | 417 |
| Third-party assets under management by asset classes | — | — |
| Fixed income | 1,472 | 1,523 |
| Multi-assets | 189 | 196 |
| Equities | 165 | 172 |
| Alternatives | 95 | 98 |
| Third-party assets under management by regions | — | — |
| America | 998 | 1,024 |
| Europe | 558 | 584 |
| Asia Pacific | 364 | 382 |
| EUR billion | 2024 | 2025 |
|---|---|---|
| Third-party net flows | 85 | 139 |
| Thereof: PIMCO | 84 | 133 |
| Thereof: AllianzGI | 0 | 6 |
Corporate and Other
| EUR million | 2024 | 2025 |
|---|---|---|
| Operating net investment income, excluding interest expenses from external debt | 419 | 474 |
| Finance income (expenses) from insurance contracts issued (net) | 0 | 0 |
| Finance income (expenses) from reinsurance contracts held (net) | 0 | 0 |
| Operating investment result | 419 | 474 |
| Operating administrative expenses | -1,418 | -1,477 |
| Operating fee and commission result | 384 | 438 |
| Operating other result | 0 | -0 |
| Operating profit | -615 | -565 |
| Non-operating items | — | — |
| Realized gains/losses (net) | 3 | -1 |
| Expected credit loss and impairments (net) | -30 | -33 |
| Result from assets and liabilities measured at fair value incl. derivatives | -223 | -339 |
| Thereof: non-operating market movements | 33 | -62 |
| Interest expenses from external debt | -762 | -758 |
| Restructuring and integration expenses | -215 | -97 |
| Amortization of intangible assets | -11 | -16 |
| Thereof: amortization of intangible assets from business combinations | -11 | -14 |
| Other | 292 | 61 |
| Subtotal | -946 | -1,183 |
| Income (loss) before income taxes | -1,561 | -1,748 |
| Income taxes | 344 | 610 |
| Net income (loss) | -1,217 | -1,138 |
| Net income (loss) attributable to: | — | — |
| Non-controlling interests | 78 | 12 |
| Shareholders | -1,295 | -1,149 |
| Income (loss) before income taxes | -1,561 | -1,748 |
| Adjustment for non-operating market movements | -33 | 62 |
| Adjustment for amortization of intangible assets from business combinations | 11 | 14 |
| Core income (loss) before income taxes | -1,583 | -1,672 |
| Income taxes related to core income (loss) | 296 | 597 |
| Core net income (loss) | -1,287 | -1,075 |
| thereof: Shareholders' core net income (loss) | -1,228 | -1,087 |
Consolidation
| EUR million | 2024 | 2025 |
|---|---|---|
| Total business volume (footnote: Total business volume comprises gross premiums written and fee and commission income in Property-Casualty, statutory gross premiums in Life/Health, and operating revenues in Asset Management.) | -746 | -623 |
| Operating insurance revenue | -81 | -56 |
| Operating profit | -4 | 1 |
| Non-operating items | — | — |
| Realized gains/losses (net) | -0 | 1 |
| Expected credit loss and impairments (net) | 0 | 0 |
| Result from assets and liabilities measured at fair value incl. derivatives | 1 | 1 |
| Thereof: non-operating market movements | 1 | 1 |
| Interest expenses from external debt | 0 | 0 |
| Restructuring and integration expenses | 0 | 0 |
| Amortization of intangible assets | -1 | 0 |
| Thereof: amortization of intangible assets from business combinations | 0 | 0 |
| Other | 4 | -1 |
| Subtotal | 4 | 1 |
| Income (loss) before income taxes | -0 | 1 |
| Income taxes | -0 | -1 |
| Net income (loss) | -0 | 0 |
| Net income (loss) attributable to: | — | — |
| Non-controlling interests | 0 | 0 |
| Shareholders | -0 | 0 |
| Income (loss) before income taxes | -0 | 1 |
| Adjustment for non-operating market movements | -1 | -1 |
| Adjustment for amortization of intangible assets from business combinations | 0 | 0 |
| Core income (loss) before income taxes | -1 | 0 |
| Income taxes related to core income (loss) | -0 | -1 |
| Core net income (loss) | -1 | -1 |
| Thereof: shareholders' core net income (loss) | -1 | -1 |